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Abstract 
Neonatal hypoxic-ischemic encephalopathy (HIE) remains a frequent cause of acute 
mortality and permanent neuropsychological handicaps such as mental retardation and 
deficits in cognitive abilities. Thrombopoietin (TPO) is a hematopoietic growth factor 
stimulating megakaryopoiesis and platelet formation. It is involved in proliferation 
signaling and anti-apoptosis pathways in the hematopoietic system. TPO and its receptors 
c-mpl are expressed in the human brain and central nervous system. There is about 50% 
similarity in sequence between TPO and erythropoietin (EPO), the latter has established 
effects on neuroprotection. The similarity in sequence between TPO and another 
neuroprotectant, neurotrophins, is also high and TPO shares the highest homology (about 
62%) with brain-derived neurotrophic factor (BDNF). Based on the above, we 
hypothesized that TPO may protect the neonatal brain from HIE. 
In our study, 7- or 14-day-old rat models for human preterm and term neural 
development underwent unilateral common carotid artery ligation. After resting for 1-2 or 
2-3 hours, they were exposed to 8% oxygen for 2 hours to induce severe or mild 
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hypoxic-ischemic (HI) damage respectively. TPO was administered daily for 7 days and 
the extent of brain damage was investigated by (i) the gross injury scores, (ii) relative 
weights of the ipsilateral hemisphere to the contralateral hemisphere and, (iii) relative 
cortex and hippocampus areas. Some p7 rats with severe damage were subjected to 
functional tests 3 weeks post-surgery before sacrifice. In an in vitro culture model, we 
further investigated the effect of TPO on the proliferation of neural stem/progenitor cells 
(NSPs) extracted from the hippocampus of mouse fetus. We investigated the proliferation 
and viability of neurospheres in response to stimulation of TPO, under the stress of 
growth factor withdrawal and hypoxia exposure. 
Our results demonstrated that HI insult significantly induced right brain damage, 
which was reduced by TPO treatment. TPO reduced the percentage damage in brain 
weight, cortex and hippocampus areas brought by HI insult in p7 rats with mild damage 1 
week post-surgery. Performance in the gross injury score was improved. TPO also 
reduced the damage in brain weight and increased the gross injury score in p7 rats with 
severe damage. The effect of TPO was sustained at 3 weeks post-surgery. Functional 
assays on grip traction test and elevated body swing test, however, were not altered by HI 
or TPO treatment. Although TPO improved the absolute brain weight of p i4 rats，the 
damage in cortex area was not significantly reduced. In the primary mouse NSP culture, 
TPO (0.2, 1，2 ng/ml) increased the total viable cell number. Hypoxia increased the 
number of neurospheres and total viable cells. TPO (0.2，2, 10，20 ng/ml) further 
increased the number of medium or large neurospheres and total viable cells when added 
to the culture exposed to hypoxia. 
In summary, our study indicates that TPO possesses neural protection function in the 
ii 
hypoxia-ischemia induced brain damage, and suggests that TPO can increase the 
proliferation of NSPs，which might help to repair the HI damage. TPO could be further 
developed as a potential neuroprotective agent, applied together with other treatment 
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1.1 Hypoxic-ischemic encephalopathy in human infants 
1.1.1 Incidence 
Hypoxic-ischemic encephalopathy (HIE) in neonates remains an important cause of 
acute mortality. From the estimation of the World Health Organization in 2000, hypoxia 
caused approximately 10% of the total mortality in infants during their first year of life in 
locations such as Hong Kong and USA. The percentage went up to 30% in some less 
developed countries. An analysis showed that asphyxia is the third dangerous direct cause 
of neonatal death and accounts for 23% of neonatal death globally (Lawn et al, 2005). 
The surviving ones have a high chance to develop permanent neuropsychological 
handicaps, for example, delayed mental and motor development, cerebral palsy, epilepsy, 
spastic hemiparesis and cognitive deficits (Ashwal and Pearce, 2001). HIE occurs at a 
rate of 2-4 per 1000 full-term births, while in low birth weight, premature newborns, the 
frequency increases to approximately 60% (Vannucci and Hagberg, 2004). It may be due 
to the fact that in premature newborns there are often numerous complications that can 
contribute to cerebral injury, for example, hyaline membrane disease, episodes of apnea 
and bradycardia, sepsis with systemic hypotension, bronchopulmonary dysplasia, and 
impaired cerebrovascular autoregulation (Roland and Hill, 1995). 
According to the clinical features, HIE can be graded into mild, moderate and severe 
using the classification system of Sarnat and Sarnat (1976). Infants showing irritability, 
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jiterriness, uninhibited Moro/stretch reflexes and sympathetic overreactivity for less than 
24 hours are graded to have mild encephalopathy. The clinical features of moderate HIE 
are lethargy, hypotonia, depressed primitive reflexes. Seizures may happen in some cases 
of moderate HIE while these are more frequently observed in infants with severe HIE. 
Other features of severe HIE include coma, hypotonia, brainstem dysfunction, autonomic 
dysfunction while increase in intracranial pressure was sometimes detected (Roland and 
Hill, 1995). In a meta-analysis of literature between 1966 and 1997, Sarnat grading was 
shown to be partial predictive of the outcomes (van de Riet et al., 1999). Infants with 
mild encephalopathy usually have little neurological deficits in long-term, while 20-40% 
of those with moderate HIE show abnormalities. For those with severe HIE, death are 
frequently observed and all survivors have neurological abnormalities. 
1.1.2 Biphasic development of HI brain damage 
Experimental and clinical studies have shown that HIE is an evolving process. The 
first phase is the primary energy failure taken place during the immediate reperfusion 
period. This is followed by a latent phase, in which a patient may have normal cerebral 
blood flow velocity detected by colour Doppler ultrasonography (lives et al., 2004) and 
normal oxidative cerebral energy metabolism as shown by magnetic resonance 
spectroscopy (Gunn, 2000). The concentration of phosphorus metabolites return to 
baseline (Cady et al., 1997). This latent phase is believed to be associated with initiation 
of the intracellular components of the signaling cascades. Then secondary deterioration 
develops and patients show delayed seizures and cytotoxic edema, extracellular 
accumulation of potential cytotoxins, failure of oxidative metabolism and ultimately 
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neuronal death (Dirnagl et ai, 1999; Gunn, 2000). This deterioration poses a prolonged 
effect and the severity is closely related to neurodevelopment impairment (Nakajima et 
a/., 2000). 
The presence of a latent phase increases the feasibility of interventions to arrest 
further cell death (Horn and Schlote, 1992). However, this therapeutic window is 
relatively short, possibly no more than 1 to 2 hours post HI insult (Kuroiwa et al, 1990; 
Vannucci and Perlman, 1997) as the cellular destruction in infants could be very rapid. 
Diagnosis of the onset and severity of HI brain injury is difficult as it may start before 
delivery and the clinical signs are not obvious. It is further obstructed if thorough 
neurological examination was hindered by severe cardiorespiratory instability, presence 
of life-support apparatus or the use of medications. Without clear diagnosis, physicians 
always prefer to treat only infants who have postasphyxial seizures. This constricts the 
window for treatment (Roland and Hill, 1995; du Plessis and Volpe, 2002). 
1.1.2.1 Initiating mechanism: energy failure in immature brain 
In newborns, the rate of cerebral energy metabolism is relatively low due to 
neuronal pre-maturation and low synaptic activity (Nehlig and Pereira de Vasconcelos, 
1993). This increases the infant's tolerance of HI when comparing with adult. But at the 
same time, the level of glucose transporter proteins in neonatal brain is comparably low 
as they rely more on ketone bodies for cerebral energy requirement (Pierre et al, 2000; 
Vannucci and Simpson, 2003). After HI insult, oxidative phosphorylation is prohibited 
and thus the metabolism switches to anaerobic glycolysis. Cerebral glucose utilization 
increases substantially and depletes the brain glucose reserve (Vannucci et al., 1994). 
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Owing to the lack of transporter, the newborn is incapable of transporting glucose across 
blood-brain barrier (BBB) quickly and the primary energy failure appears (Yager et al, 
1992). 
1.1.2.2 Biochemical cascades 
1.1.2.2.1 Excitatory amino acid receptor activation by glutamate 
During energy failure, adenosine triphosphate (ATP) depletes rapidly (Martin et al., 
1994) and then sodium and calcium ions accumulate. It causes cellular depolarization and 
activates the axon to release glutamate. Owing to the impairment of the energy-dependent 
presynaptic reuptakes (Silverstein et al, 1991; Jabaiidon et al., 2000), the glutamate is 
thus accumulated (Hagberg et al, 1987). 
The glutamate accumulation overactivates N-methyl-D-aspartate (NMDA) receptors, 
which mainly express on neurons (Follett et al, 2000), and results in an excessive influx 
of calcium into postsynaptic neurons (Choi and Rothman, 1990; Gorier et al., 1997). In 
the immature brain, NMDA receptors mediate neuronal survival, growth, differentiation 
and migration, and synaptic development (Komiiro and Rakic, 1993; McDonald and 
Johnston, 1990). To facilitate these developmental processes, immature NMDA receptors 
activate for longer time to allow higher calcium influx. This further contributes to 
vulnerability of the immature brain towards HI injury (Johnston, 1995). 
1.1.2.2.2 Intracellular calcium accumulation 
Upon HI insult, the failure of oxidative phosphorylation causes the calcium ions to 
be released from its storage (Boitano et al., 1992). The ATP-dependent pumps fail to 
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exclude Ca^^ due to energy failure while 3Na+-Ca2+ exchangers operate in an opposite 
direction to pump in calcium ions as the intracellular sodium concentration increases due 
to glutamate activation (Nachshen et aL, 1986; Kristi'an and Siesjo, 1997). These 
reactions result in intracellular calcium accumulation. 
Increased calcium in the cytoplasm activates many enzymes, for example, 
phospholipase A2 and C, which trigger calcium release from the endoplasmic reticulum 
(Grow and Barks, 2002); calpains, which digest cytoskteletal proteins (Siman and Noszek, 
1988; Siman et al, 1989); endonucleases，which degrade DNA (Ojcius et aL, 1991). 
1.1.2.2.3 Formation of free radicals 
The immature brain is particularly vulnerable to free radical injury. It is because the 
concentration of iron, which enhances the effect of free radicals, is high in the developing 
brain. The scavenging systems are also poorly expressed in the immature brain 
(Blomgren and Hagberg, 2006) 
1.1.2.2.3.1 Reactive oxygen species (ROS) 
During and following HI, components of the mitochondrial electron transport chain, 
e.g. coenzyme Q, are reduced due to the lack O2. They later auto-oxidize to produce ROS 
(Tymianski and Tator, 1996). ROS is also overproduced by cytosolic prooxidant enzymes, 
like cyclooxygenase (Chan, 2001). Calcium-activation of phospholipase A2 and C 
releases arachidonic acid from membrane phospholipids (Dumuis et al., 1988; Dumuis et 
al., 1990) and indirectly produces ROS (Schmidley, 1990). 
ROS is highly reactive and can damage proteins, nucleic acids, lipids and other 
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classes of molecules, such as glycosaminoglycans in the extracellular matrix. Damages 
on cell membrane and DNA finally lead to apoptosis (Shalak and Perlman, 2004). 
1.1.2.2.3.2 Nitric oxide (NO) 
NO is synthesized by three isoforms of nitric oxide synthease (NOS) (ladecola, 
1997). Intracellular calcium activates neuronal and endothelial NOS shortly after the 
insult (Zhang et al., 1993; Zhang et al, 1994). Later, accumulated cytokines and 
endotoxins upregulate inducible NOS in microglia, macrophages, astrocytes and 
endothelial cells (ladecola, 1997; ladecola et al., 1995; Nagafuji et al., 1994). 
NO reacts with superoxide to produce highly reactive and toxic peroxynitrite 
(ONOO"). Peroxynitrite initiates the peroxidation of lipids and the oxidization of 
sulphydryls, DNA and proteins. The decomposition products of peroxynitrite, like 
nitrogen dioxide and nitronium ions, are also highly toxic (Lipton et ai, 1993). 
NO produces cyclic guanosine-3,5- monophosphate (cGMP) (Lucas et al., 2000) 
targeting on cGMP-dependent protein kinases (Feil et al, 2005). The enzymes mobilize 
the intracellular calcium storage and increase calcium influx. It affects not only the 
primarily activated cells, but also the adjacent cells and establishes intercellular calcium 
waves (Willmott et al.’ 2000). This pathway is functional in neurons and now 
increasing evidence shows that it also affects glial cells (Baltrons et al., 2008). 
1.1.2.3 Release of inflammatory mediators 
The increase of calcium and free radicals, and the hypoxia itself, stimulate the 
expression of a number of proinflammatory genes (Dirnagl et al., 1999) and adhesion 
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molecules on endothelial cell surface (Lindsberg et al, 1996 and Zhang et ai, 1998). 
This facilitates the neutrophils to enter the brain parenchyma, followed by macrophages 
and monocytes (Garcia et al, 1994). Astrocytes and microglial cells are activated by the 
mediators and become immunologically reactive. This amplifies the inflammation signal 
cascades (Kim, 1996). 
Inflammatory cytokines induce the production of free radicals and induce glial cells 
to release excitatory amino acids (Shalak and Perlman, 2004). The cytokines also affect 
some systemic parameters, such as blood flow and body temperature, which influence the 
brain injury (Grow and Barks, 2002). The microvascular obstruction by neutrophils also 
stops the reperfusion of cerebral blood flow (del Zoppo etal., 1991). 
1.1.2.4 Mitochondrial dysfunction 
The ATP production by mitochondrion deteriorates due to the collapse of 
trans-mitochondrial membrane potential, the cytosolic calcium accumulation and the 
attack of free radicals (Zaidan and Sims, 1994). The cells cannot maintain membrane ion 
gradients and membrane depolarization occurs. This loops back to the overactivation of 
NMDA receptors (Johnston et al, 2001). 
Mitochondrial dysfunction can lead to both necrosis and apoptosis (Murphy et al, 
1999). The depletion of ATP production directly causes ionic imbalance and osmotic cell 
lysis. In brief, different proteins, for example cytochrome c (Liu et al, 1996; Yang et al, 
1997) and apoptosis-inducing factors (Susin et al., 1996), are released from apoptotic 
cells when mitochondria are damaged. The caspase family, especially caspase-3, is then 
stimulated (Kluck et al, 1997). Nuclear condensation is initiated in the presence of cell 
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cytosol and deoxyadenosine triphosphate (dATP) (Liu et al., 1996). 
1.1.2.5 Final path to death: necrosis or apoptosis 
Necrotic death is characterized by the swelling of cell, the compromise of cell 
membrane integrity, and the secondary inflammatory response (Linnik et al, 1993). On 
the other hand, early preservation of integrity in membrane and organelles, and organized 
chromatin and cytoplasmic condensation are observed in apoptotic cells. Cellular 
components are bound inside apoptotic bodies, which are taken up by adjacent cells in 
epithelia or macrophages (Gerschenson and Rotello, 1992). 
The destination of the dying cell to necrosis or apoptosis after HI insult is controlled 
by the intensity of insult, the type and location of cells, and the stage of life cycle of cells 
(LeiSt and Nicotera, 1998; Northington et al., 2001). Although necrosis and apoptosis are 
generally regarded as different death pathways in cells, they are not mutually exclusive. 
Much evidence has showed that a morphological continuum of dying neurons exists in HI 
damaged brain, with the extremes be purely apoptosis and necrosis (Portera-Cailliau et al., 
1997; Leist and Jaattela, 2001; Northington et al., 2007). In despite of that, substantial 
evidence supports that apoptosis plays a role in the neuronal death, especially in the 
immature brain (McDonald et al., 1997; Nakajima et al, 2000). Different components 
involved in apoptosis are upregulated in the immature brain, for example Bcl-2 and Bax 
(Krajewska et al, 2002), and caspase-3 (Wang et al, 2001). 
1.1.2.6 Ways to change: neuronal survival and proliferation signaling 
To rescue neural cells from apoptosis or regenerate new neurons, the PI3K 
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(phosphoinositide 3-k:inase)/Akt (protein kinase identified in the AKT virus) and 
Ras/Raf/MAPK (mitogen-activated protein kinase) signaling pathways are essential 
(Frebel and Wiese，2006). 
Survival factors bind to cell surface receptors and recruit PI3K to transmit the 
signals to Akt (Nunez and del Peso, 1998; Brunet et al., 2001). Akt phosphorylates BAD 
(Bcl-2 associated death protein) and activates pro-survival members of Bcl-2 family, like 
BC1-XL (Yang et ai, 1995; Datta et al, 1997). Akt also inhibits caspase 9 (Cardone et al, 
1998) and the expression of apoptosis-related genes (Brunet et al., 1999; Kops et al., 
1999; Tang et al, 1999). Akt is also activated in response to proliferation signals in 
mouse neural stem/ progenitor cells (NSPs) (Molina-Holgado et al, 2007) and rat adult 
hippocampal progenitors (Peltier et al., 2007). 
The extracellular signal-regulated kinase (ERK) cascade is the most well-known 
MAPK cascade (Shaul and Seger，2007). Stimuli activate small GTP binding proteins, 
like Ras. It is followed by the sequential activation of several sets of cytoplasmic protein 
kinases, with ERK as the last tier (Gomez and Cohen, 1991; Seger et al, 1992; Wellbrock 
et al” 2004). In NSPs, ERK cascades can protect against lipopolysaccharide-induced 
apoptosis (Peng et al, 2008). ERK cascades are involved in proliferation mediated by 
vascular endothelial growth factor and basic fibroblast growth factor (Xiao et al, 2007) 
and by hypoxia/reoxygenation (Sung et al, 2007). Stress, including neurotoxin and 
oxygen glucose deprivation, inhibits the ERK activation and thus hinders the proliferation 
of NSPs (Ceccatelli et al., 2004; Kalluri et al., 2007). 
1.1.3 Interventions for neonatal hypoxia-ischemia 
9 
The HI damage on brain is developed through a complicated mechanism involving 
the interplay of various biochemical pathways. The neurological outcomes of the patients 
after the HI insult are determined by multiple factors, including the progress of the insult 
(the severity, intensity and timing), the degree of maturity of the brain and also the 
characteristics of reoxygenation/reperfusion (Alvarez-Diaz et al., 2007). 
Although intense efforts have been paid, there are still no therapeutic agents proven 
useful to reduce HI brain damage and achievable in the clinical setting at present 
(Ginsberg, 2008). Researchers have done many investigations on pharmacologic agents 
targeting at different points in the mechanism (Perlman, 2006)，for example ROS 
scavenger melatonin (Carloni et al, 2008), excitatory amino acid receptor antagonist 
MgS04 (Spandou et al” 2007)，calcium channels blocker dantrolene (Gwak et al., 2008), 
and apoptosis inhibitor granulocyte-colony stimulating factor (Yata et al, 2007). Some 
other examples of therapeutic agents tested in animal models included the neurotrophin 
family，e.g. brain-derived neurotrophic factor (BDNF), neurotrophin-3 and short peptides 
derived from neurotrophic factors (Galvin and Oorschot, 2003; Kumral et al., 2006), and 
microglia inhibitor minocycline (Carty et al., 2008). 
One of the most intensely studied candidates is erythropoietin (EPO). There are 
several lines of evidence showing its neuroprotective effect. EPO protected the neurons 
from glutamate toxicity in vitro (Morishita et al, 1997) and stimulated the proliferation 
and differentiation of neural stem cells (Shingo et al, 2001; Studer et al., 2000). EPO 
exerted its effect by eliciting several signaling cascades, for example, Ras/MAPK, 
PI3K/Akt and Jak-2/NF-KB pathways (Digicaylioglu and Lipton，2001; Shingo et al., 
2001; Chong et al, 2003). Its neuroprotective effect was also proven in different animal 
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models showing reduction in infarction volume, prevention of neuronal apoptosis and 
improvement in functional outcomes (Sadamoto et al., 1998; Bernaudin et al., 1999; 
Brines et al., 2000; Siren et al, 2001; Kumral et al, 2003 and 2004). At the moment, a 
clinical trial using EPO for treatment of stroke patients is being performed (Ehrenreich et 
al., 2004). 
Among nonpharmacologic interventions, hypothermia is the most promising 
protocol to reduce risks of having brain damage after HIE. Its efficacy was tested in 
different animal models of HI (Bona et al., 1998; Gunn and Thoresen，2006) and also in 
studies of other events, for example, stroke, trauma or cardiac arrest (Perlman, 2006). It 
has been tested in several clinical trials. In a meta-analysis by Schulzke et al. (2008), five 
trials were identified. Two trials used cooling cap for selective head cooling (Gunn et al, 
1998; Battin et al,, 2001 and 2003; Gluckman et ai, 2005) and the other three used 
cooling blanket for whole body cooling (Shankaran et al., 2002; Eicher et al., 2005a and 
b; Shankaran et al., 2005). Another meta-analysis by Jacobs et al. (2008) included three 
more trials. Two of the trials used selective head cooling but were excluded by Schulzke 
owing to lack of clinical follow-up data (Akisu et al., 2003; Lin et al., 2006) and one used 
whole body cooling (Inder et al, 2004). Both meta-analyses reported that these studies 
showed improvements in the outcome of death or major disability up to 18 months, 
despite the difference in methodologies, patient characteristics and outcome definitions in 
these trials. From these analyses, the efficacy seems to be similar in patients with head or 
whole body cooling while some studies suggested that the selective approach may speed 
up the cooling and minimize the adverse effect in contrast to systematic cooling (Gelman 
et al., 1996; Gunn et al, 1998). 
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However, some studies suggested the long-term protective effect of hypothermia is 
not obvious in animal models (Dietrich et al., 1995; Johnston et al., 2000) and no such 
data was reported in clinical trials. Hypothermia may just delay the development of 
secondary cell death. In clinical trials, the hypothermia group has shown more frequent 
bradycardia and seizures, lower heart rates and platelet counts, longer dependence on 
pressors and higher prothrombin times (Schubert, 1995, Eicher et al., 2005b). A trend of 
increasing risk of anemia, coagulopathy and hypotension was detected (Schulzke et al, 
2007). Besides, the neuroprotection ability is greatly reduced or lost if the partial or 
systemic cooling is delayed (Gunn et al, 1999, Karlsson et al., 2008) and as mentioned, 
this delay is common. Therefore, a combination of hypothermia with administration of 
other therapeutic agents may help to achieve better protection (Thoresen and Whitelaw, 
2005; Barks, 2008). One example is a combination of an anesthetic gas, xenon, and 
hypothermia. This combination improves long-term functional outcome and 
histopathology score, and performed better than having either intervention alone (Hobbs 
et al, 2008). 
1.2 Animal models mimicking hypoxia-ischemia brain injury 
1.2.1 Comparisons of animal models of hypoxia-ischemia 
HIE is more a symptom complex than an isolated clinical entity. The biochemical 
reactions are complicated and highly interactive. There are several different animal 
models developed for investigation of HI injury. Some common models include rodent, 
piglet, sheep/lamb, and non-human primate (Rhesus monkey and baboon). Few studies 
used guinea pigs, cats, dogs, rabbits and bats (Painter, 1995). Studies of rodents and 
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piglets involved newborn animals while for sheep and non-human primates, mainly the 
fetuses were used. 
To monitor multiple organ function in HIE, rodents are too small in size for accurate 
assessment (Roohey et al, 1997). In consideration of brain maturation, although 
non-human primate is a close relative to human in phylogeny, its central nervous system 
(CNS) is usually more mature than human at newborn. This is also the problem with the 
sheep model. Piglets have similar maturation period to human while rodents have the 
maturation later after birth (Duhaime，2006). In general, large animals have more similar 
distribution and morphological appearance in white matter lesion to human than rodent 
models do as rodents have lower white/gray matter ratio and relatively different CNS 
anatomy (Hagberg et al,, 2002). However, a large amount of researches has been done on 
the baseline neurochemistry, physiology and neurological testing in the rodent models. 
There are many well-validated tests to evaluate the long-term results and behavioral 
outcomes post HI (Roohey et al., 1997). For piglets and sheep, well-established baseline 
data are available for acute cerebral metabolic outcomes but there are no standardized 
methods for testing their behavioral outcomes (Duhaime, 2006). The baseline data for 
non-human primate is relatively incomplete although there are ample literatures on its 
behavior assessment methods (Roohey et al., 1997). 
Therefore, the sheep and piglets are considered suitable for acute and subacute 
studies, while rodents can be used in acute as well as chronic studies for behavioral 
evaluations. And as expected, rodents are the most frequently used animals in HIE 
studies. 
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1.2.2 Development of neonatal rat model with hypoxic-ischemic damage 
In the 60’s, Levine developed the technique of combining the exposure to nitrogen 
and the unilateral common carotid artery ligation to induce unilateral anoxic lesions in the 
adult rat brain (Levine, 1960). This technique was applied to 7-day postnatal rats in later 
years and the oxygen content was adjusted to 8% balanced with nitrogen to achieve lower 
mortality (Rice et al, 1981). The damages are mainly restricted to the hemisphere 
ipsilateral to the carotid artery ligation. Although damages may sometimes extend to the 
contralateral cortex, which shares part of the blood supply from the Iigated artery, they 
are usually reversible and only present for a few hours after the insult (Towfighi et al, 
1995). 
There are different variables in this model that will affect the severity of the damage 
induced. The first one is the duration of exposure. It is not surprising that the longer the 
duration of hypoxia, the more severe the brain damage was observed and 2-3,5 h of 
hypoxia lead to a more consistent damage in most rats (Silverstein and Johnston, 1984 
and Towfighi et al., 1991). The recovery period before exposure to hypoxia is another 
factor affecting the extent of brain damage. Lee et al. (2004) showed that delaying the 
onset of hypoxia diminished cerebral injury. The degree of neuroprotective effect of the 
ligation preconditioning increased with the length of the recovery period. It implied that 
the severity of brain injury was inversely related to the recovery time. 
The variations between rats with different ages were also studied. The brain 
histology of 7-day postnatal (p7) rat was similar to that of a 32- to 34-week gestation 
human fetus or newborn infant while that of pi4 rats was comparable to that of a 
full-term newborn infant (Hagberg et al, 2002). In the early developmental stage, the 
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pups were more resistant to HI damage. The vulnerability of the brain increased with ages 
and rats at p7 showed extensive cerebral lesions (Grafe, 1994). However, independent 
groups reported conflicting results on the cerebral vulnerability between p7 and p30. 
Ikonomidou et al (1989) claimed that the vulnerability progressively decreased after p6 
while Blumenfeld et al (1992) held an opposite opinion. However, the two studies 
assessed the brain injury at different times with different parameters. Towfighi et al 
(1997) suggested there was a change in the pattern of damage at different ages. The 
cerebral cortex was more vulnerable than hippocampus in p7 rats while by pi3，the 
relative vulnerability of hippocampus drastically increased. 
Another factor affecting the severity of damage and also the response to drug is the 
strain of rat used in the experiments. A study showed that different rat strains had diverse 
severity of damage in the middle cerebral artery occlusion model of stroke. The responses 
to drugs also varied according to the strain used (Sauter and Rudin, 1995). * 
One limitation of this model is t h a t j j t ^ ^ s么 r e p e r f u s i o n h u t j n human neonatal 
c a s^ it is rare for the blood flow to stop completely and permanently. However, there is 
/ j ^ ^ x i Q other established model for mimicking the HIE in human. There are other rat 
models having transient stoppage of blood flow by clamping the middle cerebral artery 
(Cechetto et al., 1989) but this model M not include the effect of hypoxia and so at 
present, the Levine's model is still the most frequently adopted protocol for t^e research "TC-^-AA-^-^ 
related to HI insult. 
1.3 Neural stem/progenitor cells 
Neural stem cells (NSCs) are uncommitted cells having the ability to generate 
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multiple mature neural cell types (multipotentiality) and can renew unlimitedly. On the 
contrary, progenitor cells have decreases in capacity of divisions and potency (Seaberg 
and van der Kooy, 2003). The current view of CNS ontogeny suggested a founder group 
of cells capable of forming both neurons and glia in response to inductive patterning and 
differentiation cues from the environment (Panchision and Mckay, 2002). The term 
neural stem/progenitor cells (NSPs) represents both the more primitive stem cells and 
also early progenitors. 
It was not surprised to find NSCs in embryos as they are actively developing. In 
1992，researchers first isolated NSCs from the striatum, cortex, mesencephalon and spinal 
cord of developing mouse brains (Reynolds et al, 1992). At the same tine, it has long 
believed that adult CNS has little capacity to generate new neurons. But pioneer study 
dated back to 1962 by Altman suggested the possibility of neurogenesis in adult rats and 
then various groups had demonstrated neuron generation throughout life time in both 
human and rodents (reviewed in Weissman et al., 2001). Reynolds and Weiss also 
isolated cells from the striatum of adult mice, which can generate neurons and astrocytes 
in 1992. After years of study, it was found that the subventricular zone (SVZ) 
surrounding the lateral ventricles and the dentate gyrus in the hippocampus are the most 
active regions of neurogenesis in adult (Gage, 2000). 
Primary NSCs can be cultured in vitro in a serum-free medium. Spherical cell 
clusters are formed and these are called neurospheres. At the past, people believed that 
each neurosphere is a clonal multiplication from a single NSC. However, this concept 
was under doubt recently (Reynolds and Rietze，2005) and soon independent groups 
showed that the development of neuorspheres involved the aggregation and migration of 
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NSCs (Singec et al, 2006; Mori et al., 2007). This suggests that the sizes of the 
neurospheres and the number of neurospheres formed do not directly equal to the 
mitogenic potential of each NSC and the total number of NSCs respectively. However, 
the neurosphere assay is still a useful tool in determining the proliferative ability of the 
culture as a whole. 
1.3.1 Effect of hypoxia-ischemia on neural stem/progenitor cells 
There is no doubt that HI leads to extensive neural cell death in brain but its effect 
on NSPs has not been established. Levison's group performed extensive studies on NSPs 
using Rice's rodent model with HI injury but the results appear contradictory. Their first 
study in 2001 showed that HI insult in rat model leads to apoptosis in oligodendrocyte 
progenitors and reduction in number of NSCs in SVZ (Levison et al., 2001). Using the 
same model, they later reported that only early progenitors are vulnerable to HI injury 
while NSCs are spared from damage (Romanko et al, 2004). Similar result was observed 
using the mouse model (Brazel et al., 2004). This matches with the report from Skoff et 
al- (2001) about the higher susceptibility to death in oligodendroglial precursor after HI. 
However, some recent reports showed that HI can expand the number of NSPs with high 
potency and increase neurogenesis in the same rat model (Felling et al, 2006; Yang and 
Levison, 2006). 
In in vitro model, the results favor the later story. Low, but physiological level of 
oxygen (about 3%) has shown to enhance proliferation of different types of stem cells 
culture, such as NSCs, adult skeletal muscle satellite cells, marrow-derived mesenchymal 
stem cells and CD34+ marrow progenitor populations (Csete, 2005). It also enhances 
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neuron differentiation (Morrison et al, 2000; Studer et al., 2000). Other group showed 
that proliferation and neuronal differentiation of mouse NSCs are enhanced by mild 
hypoxia of 2% oxygen when compared with 20% and 4% oxygen (Horie et al, 2008). 
Further decreasing oxygen level to zero in culture also stimulates proliferation of NSCs 
from adult rats (Burgers et al, 2008). 
1.4 Thrombopoietin 
Thrombopoietin (TPO) was recognized as the c-mpl receptor ligand by several 
independent groups simultaneously (Bartley et al, 1994; Lok et al, 1994; de Sauvage et 
a/.，1994; Kuter et al., 1994; Kato et al., 1995). The c-mpl receptor shares high homology 
with other hematopoietic receptors (Vigon et al., 1992) and plays a major role in 
magakaryocytopoiesis (Methia et al, 1993). TPO is involved in the proliferation and 
maturation of megakaryocyte and its progenitor, and platelet formation (Debili et al, 
1995; Kaushansky et al, 1994). It stimulates the proliferation of erythroid progenitors in 
the presence of EPO in culture (Kobayashi et aL, 1995). Further studies showed that TPO, 
worked in synergy with interleukin-3 and/or steel factor, increases the number of 
colony-forming cells for different progenitor lineages (granulocyte/macrophage, 
erythroid and mixed colonies) when added to in vitro CD34+ blood progenitor culture 
(Kobayashi et aL, 1996; Tanimukai et al” 1997) and also administrated to normal and 
myelosuppressed mice in vivo (Kaushansky et al., 1996). These suggest its role in 
hematopoietic stem cells. This idea was confirmed by various groups showing that TPO 
sustained proliferation of hematopoietic stem cells in both in vitro models (Ku et al., 
1996; Sitnicka et al, 1996; Yagi et al” 1999) and in vivo model (Solar et aL, 1998). TPO 
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also promotes the hematopoietic lineage in human embryonic stem cell culture (Tian et 
al., 2004; Srivastava et al., 2007). 
Human TPO has 80% identity to murine TPO (Foster et al, 1994). It is primarily 
synthesized with 353 amino acids, including a secretory leader peptide of 21 amino acids. 
The circulating TPO has a molecular mass of approximately 70kDa and a half-life of 
20-30 hours in human circulation (Kuter and Begley, 2002; Wolber and Jelkmann, 2002). 
It consists of 2 domains: a carbohydrate-rich carboxy-terminus for protein stability and a 
receptor-binding domain. This receptor-binding domain shares a significant homology 
with that of neurotrophins, for example BDNF and EPO (Li and Dai, 1995). TPO and 
EPO share about 50% homology in amino acid sequence, while TPO and BDNF share 
about 62% homology. These molecules are potential neuroprotectants against HI damage. 
The main production site of TPO is the liver in both human fetus and adult while 
other tissues, for example, kidney, spleen and bone marrow, also express TPO mRNA 
(Wolber et al., 1999). Besides in hematopoietosis-related organs, TPO mRNA is detected 
in human brain (Columbyova et al., 1995; Li et al, 1996) and CNS (Dame et al, 2003). 
Its receptor, c-mpl receptor, is also present in the brain and CNS as well (Ehrenreich et al., 
2005). This suggests that TPO may also have an effect on the nervous system. In normal 
healthy human, the concentration of TPO in blood varied as reported in different 
publications, ranging from 20 to 240 pg/ml in plasma or serum (reviewed in Wolber and 
Jelkmann, 2002). In general, the plasma TPO concentration is elevated in 
thrombocytopenic states and is lowered during thrombocytosis (Jelkmann, 2001). A 
recent study suggested that TPO does not cross the BBB normally (Matsubara et al., 
2005). However, it is well-established that HI disrupted BBB function and increased 
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permeability towards plasma protein (Ikeda et al., 1999). Thus, it is highly possible that 
TPO can cross the BBB after HI and go from the blood stream to enter the brain 





ionic imbalance , .. 
accumulation 
,, intracellular Ca2+ ^ • mitochondrial 
osmotic cell swelling accumulation \ - damage 
/ t 
‘ \ free radical 
enzyme I Z production ,’ 
activation inflammatory 丨 cytochrome c 
/ mediators / release 
membrane / 
degradation DNA damage caspase 3 activation 
NECROSIS APOPTOSIS 
Continuum 
Fig 1.1 Simplified diagram of HI mechanism showing the different biochemical 
reactions initiated by energy failure and ended in necrotic and apoptotic cell death. 
21 
Q ^ survival signals _ 、— 
Z ‘ — ^ s m a membrane 
^ ^ transmembrane receptors 一 ^ 
PI3K 
s , i P D K - l l U 
^ p \ 
Cbci-XQ 1 L © 
(BAD) J - V inactive \ 
Xaspase y 阳父。 ( R a f ) 
/ — — N 伞 \ \ 
\ I apoptotic gene y MEK ) 
^Af expression \ 
\\ ^ 
f Apoptosis 
Fig 1 2 Brief review of several cascades of PI3K/Akt pathway and ERK pathway of 




1. To evaluate effects of TPO on neuroprotection against hypoxic-ischemia 
brain damage in an in vivo model of neonatal rats. 
Mild and severe hypoxic-ischemia brain damages were induced in neonatal rats of 
two different postnatal ages, p7 and pi4. TPO was injected daily for 7 days and 
then rats were sacrificed for efficacy measurement. The effect of TPO was 
measured using brain weight, gross damage and histology. Functional assessments 
were performed for medium-term effect measurement. 
2. To investigate effects of hypoxia and TPO on the proliferation of the 
primary neural stem/ progenitor cells in culture. 
Different concentrations of TPO and hypoxia condition were applied during the 
culturing of the primary neural stem/ progenitor cells extracted from the 
hippocampus of El 5 mouse embryos. The proliferative effect was assessed by the 




Materials and Methodology 
3.1 Establishment of neonatal rat model of HI brain damage and effects of TPO on 
neural protection 
3.1.1 Animal protocols 
All procedures were performed in accordance to guidelines approved by the Animal 
Ethics Committee of The Chinese University of Hong Kong, Pregnant Sprague-Dawley 
(SD) rats were bred and kept in the Laboratory Research Unit of The Laboratory Animal 
Services Center, The Chinese University of Hong Kong. They were maintained under a 
12:12 h light:dark cycle and allowed food and water ad libitum. Rat pups were delivered 
naturally and kept with their dams. 
3.1.2 Induction of HI brain damage in neonatal rats 
On postnatal day 7 or 14, they were weighed and those with body weight within the 
range of 12 to 15 g or 20 to 30 g respectively were randomly allocated into three groups: 
sham-operated group, vehicle-treated group and TPO-treatment group. HI brain damage 
was induced in vehicle and treatment groups. The pups were first anesthetized by diethyl 
ether (Lab-Scan Analytical Sciences, Labscan Asia Co. Ltd., Bangkok, Thailand). An 
incision was made along the midline on its neck and the right common carotid artery was 
exposed (Fig 3.2A). The artery was ligated with a 4-0 mersilk sterile nonabsorbable 
suture (Ethicon, Inc., Johnson & Johnson's, Belgium) and cut between the knots to ensure 
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complete stoppage of blood flow (Fig 3.2B). The wound was stitched up and the whole 
procedure was finished within 7 min (Fig 3.2C). 
The pups were then allowed to rest in a temperature-controlled incubator at 37 °C for 
different durations, including (i) 1-2 h and (ii) 2-3 h, to induce (i) severe and (ii) mild 
brain damage. After recovery, the pups were placed inside the hypoxia chamber and 
exposed to humidified gas of 8% oxygen balanced with nitrogen for 2 h at 37 °C. 
Sham-operated rats underwent the same surgical procedure but did not receive the artery 
ligation and hypoxia exposure. All pups were finally returned to their dams. 
3.1.3 Treatment with TPO 
Lyophilized recombinant TPO (Peprotech, Inc., Rocky Hill, New Jersey, USA) was 
dissolved in phosphate-buffered saline, pH 7.4 (PBS) (Gibco, Invitrogen Corporation, 
Grand Island, New York, USA) to the concentration of 2 ng/}il. The treatment group 
received TPO (20 [ig/kg body weight) by intraperitoneal (i.p.) injection daily for 7 days 
(Ehrenreich et al., 2005). The first injection was given immediately after the hypoxia 
exposure. The vehicle-treated group received PBS only. 
3.1.4 Sacrifice of rats 
At 1 week or 3 weeks post-surgery, the rats were weighed and then sacrificed. The 
time point of 1 week post-surgery was a short term observation while 3 weeks 
post-surgery was a medium term observation to demonstrate the effect of TPO two weeks 
after its administration were stopped. The anesthetic was made up of ketamine 10% 
(Alfasan, Woerdan, Holland), xylazine 2% (Alfasan, Woerdan，Holland) and 0.9% 
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sodium chloride solution (B.Braun Medical Industries, Malaysia) in the ratio of 3:2:3. 
Blood was drawn by heart puncture and added to EDTA micro-tubes (Sarstedt, 
Aktiengesellschaft & Co., Germany). Buffered formalin (10%) was injected into the left 
ventricle and exited through an incision made on the right atrium to flush out the 
remaining blood. 
3.1.5 Read-out measurements 
All measurements were performed in a blinded-manner. The investigators had no 
prior knowledge on the treatment group of the specimen. 
3.1.5.1 Brain weight 
The whole brain was collected and its weight was measured. The cerebellum was 
detached and the left and right cerebral hemispheres were separated for weight 
measurement. The severity of brain damage was calculated by the formula: Percentage 
damage = (C-I)/C x 100, where C and I denote the weight of the contralateral (left) and 
ipsilateral (right) hemispheres respectively (modified from Calvert et al., 2002). 
3.1.5.2 Gross injury assessment of the right hemisphere 
The whole brain was examined by naked eyes to detect any abnormality on the 
surface (Vannucci et al, 1995 and Kellert et al, 2007). The gross damage on the 
ipsilateral hemisphere, including patches, atrophy, liquefied structure etc., was scored 
according to the scale: 0 = intact hemisphere with no observable damage; 1 = <25% of 
the hemisphere with observable damage; 2 = damage on 25-50% of the hemisphere; 3 = 
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50-75% damage was observed; 4 = over 75% of the hemisphere was damaged. 
3.1.5.3 Histology 
The whole brain collected was fixed in 10% buffered formalin for one week. The 
fixed tissues were dehydrated and then embedded in paraffin block for sectioning of the 
coronal area. 
Three 5-|j.m sections, 400 |a.m apart from one another, were taken at the widest part 
of the cerebral hemisphere of each rat. The sections were stained with hematoxylin and 
eosin (H&E) and examined under light microscopy. Digital pictures of the sections were 
taken at 40X magnification and the cortex and hippocampus areas of the two hemispheres 
were measured using the Spot Advance software (Fig 3.3). The percentage of tissue loss 
was calculated by the similar formula used in brain weight: Percentage damage = (C-I)/C 
X 100，where C and I denote the areas of the contralateral and ipsilateral hemispheres 
respectively. From each brain, the results on the area and damage were calculated from 
mean values of the three sections. 
3.1.5.4 Blood cell count 
Red blood cells, white blood cells and platelets were counted using a 
haemocytometer. Whole blood was diluted in PBS for red cell counting. The whole blood 
was diluted in 2% acetic acid to lyse all red blood cells for white cell count. Blood was 
diluted in 1% ammonium oxalate and left overnight for lysing all other cells before 
platelet counts. 
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3.1.5.6 Functional assessments 
Rats were tested for their sensorimotor functions at 3 weeks after surgery. All tests 
were performed on one day before sacrifice and in the same order for all rats. 
3.1.5.6.1 Grip traction test 
As adopted and modified from the test developed by Combs and D'Alecy (Combs 
and D'Alecy, 1987), a horizontal rubber tubing (0.5 cm in diameter) was placed at 30 cm 
above the table. The rats were placed on the tubing so that they were hung onto the tubing 
by their forepaws (Fig 3.4). The time of falling was measured. If the rats stayed for 5 min, 
the test was stopped. 
3.1.5.6.2 Elevated body swing test 
Borlongan and Sanberg (1995) developed this test for detecting asymmetrical motor 
behavior and this test was further modified by Roof et al. (2001). The rats were held by 
the base of their tails and elevated from the table. The direction of their first body swing, 
which defined as an upper body turn of over 10 degrees, was recorded for 30 trials. The 
trials were separated into 3 sets of 10 trials with rest of about a minute in between. The 
percent of turns made to the side contralateral to brain damage, i.e. the left side, was 
determined. Normal rats would show no side bias while damaged rats would have high 
tendency to turn toward the left. 
3.1.5.7 Statistical analysis 
Differences in mortality among the sham-operated, vehicle-treated and 
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TPO-treatment groups were compared using Fisher's exact test. Differences in body 
weight, brain weight, cortex and hippocampus areas, blood cell counts and the percentage 
difference of the two hemispheres in the weight and the areas among the three groups 
were compared using One-way analysis of variance (ANOVA). When a significant result 
was observed, the post hoc test was performed using Tukey's test to reveal 
between-group differences. Difference in damage scores on gross injury of the 
hemisphere among the three groups was identified using Kruskal-Wallis test. For 
functional outcomes, including the time of falling in grip traction test and the percentage 
of contralateral turns, discrepancies among the three groups were revealed by One-way 
ANOVA. When significance was present, post hoc test was performed using Tukey's test. 
P value < 0.05 was considered significant. The Kruskal-Wallis test was performed using 
GraphPad Prism while other statistics were performed using SPSS software. 
Experimental results are expressed as mean 土 standard error of means (SEM). 
3.2 Establishment of in vitro model of primary mouse NSPs and the effect of TPO on 
their proliferation 
3,2.1 Mouse embryo dissection for the extraction of NSP 
Institute for Cancer Research (ICR) mice were killed by cervical dislocation on day 
15 of pregnancy. The uterus holding the embryos was dissected out and washed with 
sterile PBS. Further micro-dissection was performed under a dissecting microscope. El5 
embryos were separated from the amnion and the brains were dissected. The 
hippocampus area of the embryos was collected and kept in Neurocult neural stem cell 
(NSC) basal medium (mouse) (StemCell Technologies, Inc., Vancouver, BC, Canada). 
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After dissection, the tissues were allowed to settle and the medium was drawn out. 
Trypsin-EDTA (0.05%), which was diluted from 5% trypsin-EDTA (Gibco) using 
Iscove's Modified Dulbecco's Medium (IMDM) (Gibco), was added and they were 
incubated in a 37°C water bath for 10 min. The tissues were further triturated using a 
PI000 pipetmen. Equal volume of IMDM with 2% fetal bovine serum (FBS) (Gibco) was 
added to neutralize and dilute the trypsin. The cells were passed through a cell strainer 
with 40 p.m nylon mesh (BD Falcon, Franklin Lakes, New Jersey, USA). A double 
volume of PBS was used to wash out more cells. The filtrate was then centrifuged at 150 
X g for 5 min and the pellet was resuspended in complete proliferation medium to a cell 
density of 1 x 10^/ml in a tissue culture flask. The complete proliferation medium was 
consisted of Neurocult NSC basal medium with proliferation supplement (StemCell 
Technologies), further supplemented with 20 ng/ml epidermal growth factor (EGF) 
(Peprotech, Inc.) and 20 ng/ml basic fibroblast growth factor (bFGF) (Peprotech, Inc.). 
The culture was marked as PO cells and maintained in 5% CO2 at 37 °C. 
3.2.2 CulturingofNSP 
When neurospheres were formed and floating on the medium after 4 to 5 days, the 
cells were ready for passage. The medium was collected and the flask was rinsed with 
PBS. The neurospheres were centrifuged at 20 x g for 5 min. The pellet was gently 
washed with PBS and the spheres centrifuged at 20 x g for 5 min again. Trypsin-EDTA 
(0.05%) was added to the cells and the tube was incubated in 37 °C water bath for 7 min. 
The clumps were triturated using a PI000 pipetmen and IMDM with 2% FBS was added. 
The cells were centrifuged at 150 x g for 5 min. The pellet was washed with PBS and the 
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cells were centrifuged at 150 x g for 5 min. The cells were resuspended in complete 
proliferation medium to a cell density of 5 x lO'^ /ml and cultured in 5% CO2 at 37�C. 
Only P3 to P7 cells were used in the following assay. 
3.2.3 Immunofluorescence staining for stem cell markers 
To confirm the stem cell identity of the neurospheres, immunofluorescence staining 
was performed. The neurospheres were collected by centrifugation at 20 x g for 5 min. 
The pellet was resuspended gently in Dulbecco's Modified Eagle's Medium 
(D-MEM)/F-12 (1:1) (Gibco) supplemented with 2% FBS. The neurospheres were then 
added to a glass coverslip coated with poly-L-ornithine (Sigma, Saint Louis, Missouri, 
USA) in 24-well plate. The plate was incubated in 5% CO2 at 37°C for 3 h. When the 
neurospheres attached to the coverslip, the medium was removed and the coverslip was 
washed with PBS. The neurospheres were fixed with 4% paraformaldehyde for 20 min. 
Then Triton-X 100 (Sigma) was used to permeabilize the cell membrane for 5 min. The 
coverslip was blocked with 10% normal goat serum for 30 min. Rabbit anti-Musashi-1 
affinity purified polyclonal antibody (1:100) (Chemicon，Millipore, MA, USA) was 
added and the plate was incubated in 4°C in dark overnight. Goat anti-rabbit (H+L) FITC 
secondary antibody (Zymed, Invitrogen Corporation, South San Francisco, CA, USA) 
was added at the dilution 1:100 and incubated with the coverslips for 30 min in the dark. 
Finally, the coverslip was taken out and antifade aqueous moutant with propidium iodide 
(Sigma) was used to mount the coverslip on a clean glass slide for digital image capture. 
3.2.4 Neurosphere assay with different combinations of mitogens 
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Single cells from the neurosphere culture (P3 to P7) were dissociated and diluted to 
a cell density of 1 x lOVml in Neurocult NSC basal medium with proliferation 
supplement. EGF and bFGF were added at different combinations, including (i) 20 ng/ml 
EGF and 20 ng/ml FGF; (ii) 20 ng/ml bFGF and (iii) 20 ng/ml EGF. Each culture 
combination was performed in triplicate for each independent experiment. The cells (200 
|Lil/well) were seeded in 96-well plate. 
The culture plate was incubated in 5% CO2 at 37�C for 8 to 12 days until the cells 
were densely packed as round, floating spheres instead of irregular cell clusters or 
adhesive differentiated spheres. The number of spheres formed was first counted and they 
were classified into three groups: small, medium and large, according to their sizes under 
inverted light microscope (Fig 3.5) (Ciccolini and Svendsen, 1998). The spheres were 
then triturated into single cells using a P200 pipetmen. The total number of cells was 
counted and the viability was estimated using the trypan blue (StemCell Technologies) 
exclusion method. 
3.2.5 Neurosphere assay with different concentrations ofTPO 
The plate was first prepared as mentioned in 3.2.4 with 20 ng/ml EGF. TPO was 
added at 0, 0.1，0.2, 1，2，10, 20 and 200 ng/ml. Each concentration was performed in 
triplicate wells. The plate was placed in an incubator of 5% CO2 at 37 °C for 8 to 12 days 
and the cells were harvested as mentioned in 3.2.4. 
3.2.6 Neurosphere assay under hypoxia 
The plate was prepared as mentioned in 3.2.4. TPO was added at 0，0.2, 2，10 and 20 
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ng/ml. Each concentration was performed in triplicate wells. For each experiment, 
duplicate plates were prepared with one plate incubated in 5% CO2 at 37"C as the 
normoxic control. The other plate was placed inside the hypoxia chamber (Billups 
Rothenberg Inc., Del Mar, Carlifonia, USA), which was flushed with 5% CO2 in 95% 
nitrogen at the rate of 20 L/min for 10 min. The inlet and outlet taps were then closed and 
the whole chamber was placed in an incubator at 37�C. The cells were exposed to 
hypoxia for 16 h and the plate was then taken out of the chamber and placed back to an 
incubator of 5% CO2 at 37°C. The cells were harvested as mentioned in 3.2.4. 
3.2.7 Statistical analysis 
Differences in viability and the number of neurospheres and total viable cells 
between the cultures with EGF and bFGF and the EGF-only or bFGF-only cultures, and 
the no-TPO cultures and the TPO treated cultures were compared using Wilcoxon signed 
ranks test. This statistics were performed using SPSS software. The trends of different 
parameters under the hypoxic and normoxic conditions were fitted into the multilevel 
models using the method of restricted iterative generalized least-squares algorithm of 
MLn for Windows software package. P value < 0.05 was considered significant. 
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Postnatal day 
0 —r— Labor 
7 or 14 - j— HI induction 
a) Ligation of the right common carotid artery 
b) Resting for (i) 1-2 h or (ii) 2-3 h 
c) Exposure to 8% oxygen for 2 h 
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I Blood cell count 
： Body and brain weight measurement 
: Gross injury scoring 
27 丁 Func t iona l a s s e s s m e n t Fixation of brain tissues for 
histochemistry 
Grip traction test 
Elevated body swing test ‘, 
28 Sacrifice for 
measurements 
Fig 3.1. Flow chart of the rat model experiment. The HI damage was induced on 
postnatal 7 or 14 days and the TPO treatment was applied on the damaged rats. Data 
measurements were done 1 week post-surgery. In the model of p7 rats with severe HI 
damage, some animals were harvested on 3 weeks post-surgery and their sensorimotor 
functions were assessed 1 day before sacrifice. 
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Fig 3.2 Procedures of artery ligation. (A) The right common carotid artery was isolated 
from muscles and nerve. (B) It was cut after ligation and (C) the incision was finally 
closed. 
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Fig 3.3 Histology of brain sections. The coronal section was taken from the widest part 
of the cerebral hemisphere (dotted line) and was stained with H&E. The areas of the 
cortex (shaded in red) and of the hippocampus (shaded in blue) were measured using 
Spot Advance software. (Illustration of brain was adopted from Felling et al., 2006) 
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Fig 3.4. An illustration of the grip traction test. The rats were placed on a rubber tubing so 
that they were hung onto the tubing by their forepaws. The time of falling was measured. 
(Adopted from Bona et al, 1997) 
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Fig 3.5. Neurospheres formed in neurosphere assay. The neurospheres were classified 
into three sizes: small, medium and large. Small neurospheres (indicated by blue arrow) 
usually had diameter of less than 50 \im and were less spherical in shape. Medium 
neurospheres (indicated by red arrow) were larger spheres with diameter approximately 
5 0 - 150 \im. Large neurospheres (indicated by yellow arrow) had diameter over 150 ^.m. 
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Chapter 4 
Effects of thrombopoietin on neonatal rat models of 
hypoxia-ischemia brain damage 
4.1 Summary of experimental settings 
Mild and severe HI damage were induced in both p7 and p l 4 rats by having 
different resting times (2-3 and 1 -2 h respectively) before the exposure to hypoxia for 
2 h. Damaged rats were randomly allocated into the TPO-treatment and vehicle-
treated groups, which received TPO at 20 |ig/kg body weight and PBS daily 
respectively for 7 days. The sham-operated group experienced neither artery ligation 
nor hypoxia. Rats were sacrificed 1 week post-surgery for measurements of body and 
brain weight, cortex area, hippocampus area and blood cell count. In the model of p7 
rats with severe HI treatment, some animals were sacrificed 3 weeks post-surgery for 
additional functional assessments, including the grip traction test and the elevated 
body swing test. 
4.2 Results 
4.2.1 Mortality 
Sample size and mortality of animals are described in table 4.1. The mortality of 
the three groups was similar in all HI models. The number of dead animals included 
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those died after the start of the treatment schemes. Death caused by anesthetics 
overdose or surgical accident, which was occurred before any injection was excluded. 
4.2.2 Effects of TPO on p7 mild damage model 1 week post-surgery 
4.2.2.1 Body and brain weights 
The HI insult caused a decrease in the body weight of the animals (p = 0.002, 
vehicle-treated group [n = 16] vs. sham-operated group [n = 16]). TPO treatment [n = 
15] did not cause any difference in the body weight from the vehicle-treated group 
(Fig 4.1 A). 
At the same time, the HI insult reduced the total brain weight in the 
vehicle-treated group (p = 0.003, vs. sham-operated group). The TPO-treatment group 
had similar total brain weight to the vehicle-treated group (Fig 4.IB). The cerebellum 
weight of the three groups had no significant differences (p = 0.680). 
The weight of right (ipsilateral) hemisphere was reduced by the HI insult (p < 
0.0005, vehicle-treated group vs. sham-operated group). A reduction in weight was 
also observed in the left (contralateral) hemisphere after the HI insult (p = 0.015, 
vehicle-treated group vs. sham-operated group). No statistical differences were 
observed between the TPO-treatment and vehicle-treated groups in these two weights 
(Fig 4.1C). 
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The percentage damage was calculated by the formula: (C-I)/I x 100，C denoted 
the weight of the left (contralateral) hemisphere and I denoted that of the right 
(ipsilateral) hemisphere. The HI insult brought significant damage to the animals (p = 
0.001, vehicle-treated group vs. sham-operated group). TPO treatment reduced this 
damage (p = 0.028，vs. vehicle-treated group) and the TPO-treatment group had no 
significant difference from the sham-operated group (Fig 4.ID). 
4.2.2.2 Gross injury score 
Statistically, the vehicle-treated group showed significantly different gross injury 
score from the sham-operated group (p < 0.005). The TPO-treatment group showed 
no difference from the sham-operated group but also no difference from the 
vehicle-treated group (Table 4.2). 
4.2.2.3 Cortex and hippocampus area 
The right cortex area was reduced by the HI insult (p = 0.001, vehicle-treated 
group vs. sham-operated group). TPO treatment increased the right cortex area (p = 
0.019，vs. vehicle-treated group) and the area of the TPO-treatment group was similar 
to that of the sham-operated group. For the left cortex, the HI insult also caused a 
decrease in area (p < 0.0005, vehicle-treated group vs. sham-operated group). The 
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TPO-treatment group was similar to the vehicle-treated group (Fig 4.3 and 4.4A). 
When we compared the cortex areas of the two hemispheres, a significant 
damage was observed in the right cortex after the HI insult (p = 0.006, vehicle-treated 
group vs. sham-operated group). TPO treatment reduced the percentage damage (p = 
0.030，vs. vehicle-treated group) and the damage of the TPO-treatment group was 
similar to that of the sham-operated group. (Fig 4.4B) 
The right hippocampus area was also reduced by the HI insult (p = 0.005， 
vehicle-treated group vs. sham-operated group). TPO treatment increased this area (p 
=0.004，vs. vehicle-treated group) and the area of the TPO-treatment group was 
similar to that of the sham-operated group. For the left cortex, the difference among 
the three groups did not reach statistical significance (p = 0.052) (Fig 4.3 and 4.4C). 
Significant damages in the right hippocampus were observed after the HI insult 
(p = 0.002，vehicle-treated group vs. sham-operated group). TPO treatment reduced 
the damage (p = 0.019，vs. vehicle-treated group) to a level similar to that of the 
sham-operated group. (Fig 4.4D) 
4.2.2.4 Blood cell counts 
No differences were observed in the white and red cell counts in the three groups. 
For platelet count, there was a trend that a difference was present among the three 
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groups as revealed by ANOVA (p = 0.065) (Table 4.6). 
4.2.3 Effects of TPO on p7 severe damage model 1 week post-surgery 
4.2.3.1 Body and brain weights 
The severe HI insult led to a decrease in the weights of the body, the total brain 
and the right hemisphere in the animals (p < 0.0005 in the three comparisons, 
vehicle-treated group [n = 27] vs. sham-operated group [n = 26]). The weight of left 
hemisphere was also decreased (p = 0.001). TPO treatment [n = 26] did not cause any 
difference in these weights from the vehicle-treated group (Fig 4.5 A to C). 
After the severe HI insult, the vehicle-treated group had significant damage of 
the right hemisphere to the left hemisphere (p < 0.0005, vs. sham-operated group). 
TPO treatment reduced the damage (p = 0.027, vs. vehicle-treated group) but it could 
not reverse the damage completely and its damage in brain weight was still 
significantly higher than that of the sham-operated group (p < 0.0005) (Fig 4.5D). 
4.2.3.2 Gross injury score 
The vehicle-treated group showed different scores from the sham-operated group 
(p < 0.0005). TPO treatment led to significantly lower score (p < 0.05, vs. 
vehicle-treated group). There were no statistical differences between the 
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TPO-treatment and sham-operated groups (Table 4.3). 
4.2.3.3 Cortex area 
The right cortex area was reduced by the severe HI insult (p < 0.0005, 
vehicle-treated group vs. sham-operated group). Although significance was not yet 
reached, a trend that TPO treatment increased the right cortex area was observed (p = 
0.076，vs. vehicle-treated group). However, this increase was unable to reverse the HI 
damage completely and the right cortex area of the TPO-treatment group was still 
lower than the sham-operated group (p = 0.007) (Fig 4.6 and 4.7A). 
When we compared the relative cortex areas of the two hemispheres, a 
significant damage was observed after the HI insult (p < 0.0005, vehicle-treated group 
vs. sham-operated group). A trend of reduction in damage was observed in 
TPO-treatment group (p = 0.083, vs. vehicle-treated group) but still the damage of the 
TPO-treatment group was higher than that of the sham-operated group (p = 0.009) 
(Fig 4.7B). 
4.2.3.4 Blood cell counts 
No differences were observed in the white and red cell counts in the three groups. 
For platelet count, there was a trend that a difference was present among the three 
groups as revealed by ANOVA (p = 0.091) (Table 4.6). 
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4.2.4 Effects o f T P O on p7 severe damage model 3 week post-surgery 
4.2.4.1 Body and brain weights 
A trend of having a difference in the body weight among the three groups was 
observed (p = 0.070) (Fig 4.8A). 
The HI insult caused the weights of the total brain to decrease (p < 0.0005， 
vehicle-treated group [n = 19] vs. sham-operated group [n = 12]) (Fig 4.8B). TPO 
treatment [n = 21 ] increased the weight when compared with the vehicle-treated group 
(p = 0.034). However, the increase in weight in the TPO-treatment group could not 
compensate the reduction in weight after HI insult entirely and the weight of the 
TPO-treatment group were still significantly lower than that of the sham-operated 
group (p = 0.010). 
For the weight of the right hemisphere, it was reduced due to the HI insult (p < 
0.0005, vehicle-treated group vs. sham-operated group) (Fig 4.8C). It was improved 
by TPO treatment (p = 0.016，vs. vehicle-treated group) but still lower than the 
sham-operated group (p = 0.002). 
For the left hemisphere, although the result from ANOVA did not reach 
significance (p = 0.059), it showed a trend that a difference was present among the 
three groups (Fig 4.8C). 
The HI insult led significant damage in the weight of the right hemisphere to the 
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left hemisphere in the animals 3 weeks post-surgery (p < 0.0005, vehicle-treated 
group vs. sham-operated group). The TPO-treatment reduced the damage significantly 
(p = 0.004，vs. vehicle-treated group) but still its damage was higher than the 
sham-operated group (p = 0.003) (Fig 4.8D). 
4.2.4.2 Gross injury score 
The vehicle-treated group showed higher score than the sham-operated group (p 
< 0.005). TPO treatment improved the score as the TPO-treatment group had 
significantly different score from the vehicle-treated group (p < 0.05). There were no 
statistical differences between the TPO-treatment and sham-operated groups (Table 
4.4). 
4.2.4.3 Blood cell counts 
The white cell, red cell and platelet counts were similar in the three groups (p = 
0.278，0.568 and 0.826 respectively) (Table 4.6). 
4.2.4.4 Functional outcomes 
In the grip traction test and elevated body swing test, the three groups 
showed no significant differences (p = 0.225 and 0.188 respectively) (Fig 4.9). 
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4.2.5 Effects of TPO on pi 4 severe damage model 1 week post-surgery 
4.2.5.1 Body and brain weights 
The body weight of the animals was reduced by the HI insult (p 二 0.024， 
vehicle-treated group [n = 24] vs. sham-operated group [n = 11]). There was a trend 
that TPO treatment [n = 26] brought improvement to the animals (p = 0.056, vs. 
vehicle-treated group). The TPO-treatment group had similar body weight with the 
sham-operated group (Fig 4.1 OA). 
The total brain weight was reduced after HI insult (p < 0.0005，vehicle-treated 
group vs. sham-operated group). TPO treatment brought improvement to the weight 
when compared with the vehicle-treated group (p = 0.010) and the improvement 
brought the weight of the TPO-treatment group similar to the sham-operated group 
(Fig 4.1 OB). 
For the right hemisphere, the HI insult reduced its weight (p < 0.0005, 
vehicle-treated group vs. sham-operated group) (Fig 4.IOC). TPO treatment increased 
the weight of right hemisphere (p = 0.013，vs. vehicle-treated group). However, the 
reversal by TPO treatment was only partial and the weight of the right hemisphere of 
the TPO-treatment group was still lower than the sham-operated group (p = 0.005). 
For the left hemisphere, the vehicle-treated group had lower weight than the 
sham-operated groups (p = 0.010). Pups with TPO treatment showed higher weight 
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than the vehicle-treated group (p = 0.007) and similar to the sham-operated group (Fig 
4.10C). 
The vehicle-treated group had higher damage of the right hemisphere relative to 
the left hemisphere when compared with the sham-operated group (p <0.0005) (Fig 
4.10D). Although TPO treatment improved the absolute brain weights, the relative 
difference in the two hemispheres was similar to the vehicle-treated group (p = 0.185) 
and it was higher than that in the sham-operated group (p < 0.0005) (Fig 4.10D). 
4.2.5.2 Gross injury score 
The gross injury score was higher in the vehicle-treated than in the 
sham-operated group (p < 0.0005). This difference was also evident in between the 
TPO-treatment group and the sham-operated group (p < 0.05)，while the 
TPO-treatment and vehicle-treated groups had no difference (Table 4.5). 
4.2.5.3 Cortex area 
The right cortex area was reduced by the HI insult (p = 0.003, vehicle-treated 
group vs. sham-operated group). TPO treatment did not affect the right cortex area 
when compared with the vehicle-treated group (Fig 4.11 and 4.12A). 
When we compared the cortex areas of the two hemispheres, a significant 
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damage was observed after the HI insult (p = 0.005, vehicle-treated group vs. 
sham-operated group). The damage of the TPO-treatment group was similar to that of 
the vehicle-treated group (Fig 4.12B). 
4.2.5.4 Blood cell counts 
The white cell, red cell and platelet counts were similar in the three groups (p = 
0.529，0.167 and 0.851 respectively) (Table 4.6). 
4.3 Discussion 
The Levine rat model of HI damage has been widely adopted in the study of the 
pathobiology of HI and the potential therapeutic interventions against its damage. 
This model was mainly adopted in p7 rats but recent studies showed that p7 rat has 
their brain histology only comparable to that of pre-term infants but not full-term ones. 
P14 rats are more suitable for representing the brain histology of a full-term newborn 
(Hagberg et al., 2002). In this study, we successfully established a reproducible HI 
model using both p7 and p i 4 rats. The damage was observed consistently in different 
outcome measurements in the animals 1 week and 3 weeks post-surgery. A 
summary of the effects of HI and TPO on these outcomes is presented in Table 4.7. In 
literatures, the use of p i 4 is a relatively new idea and the majority concentrated on the 
use of p7 rats. The damages of our rat models in this article were similar to the 
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previously published data on Tanshinone IIA of our lab using similar model (Xia et al, 
2005). Although the absolute value of the damage varied, the trend of the HI damage 
development in our rat models, e.g. the reduction of the weight of ipsilateral 
hemipshere and cortex area in both 1 week and 3 weeks post-surgery, was similar to 
other studies using similar rat models (Feng et al., 2005; Kabaku§ et al., 2006; Yata et 
al, 2007; Zhao et al., 2007) 
In clinical practice, damages of varied severities were observed. To achieve 
different degrees of damages in rat model, the duration of ligation preconditioning 
was varied (Lee et al, 2004). Lengthening the recovery time after ligation can reduce 
the severity of brain injury induced after the exposure of hypoxia. By having two 
different resting periods after ligation in our experiment, two models with different 
degrees of damage, classified as mild and severe damage, were established. The 
different severities of damages brought by the two HI treatments were reflected in 
different measurements. For example, the relative damage of right hemisphere in 
terms of weight was 11.3 土 2.4 % (mean ± SEM) in the mild damage model at 1 week 
post-surgery (Fig 4.ID) and was 21.6 土 1.7 % in the severe model (Fig 4.5D). A 
similar degree of damage was observed in the cortex area, which was 16.9 土 5.3 % 
and 26.2 土 4.6 % in the mild and severe models (Fig 4.4B and 4.7B) respectively. 
Among many potential therapeutic agents, we were particularly interested in 
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TPO due to several characteristics of TPO. Firstly, in the human brain and CNS, TPO 
receptor, c-mpl receptor (Ehrenreich et al., 2005) and TPO mRNA (Columbyova et a l , 
1995; Li et al., 1996; Dame et al., 2003) were detected. This suggests that TPO may 
have an effect on the nervous system and we speculated that TPO might act on the 
neural stem cell population since TPO is a non-redundant cytokine for the sustained 
proliferation of hematopoietic stem cells (Ku et al, 1996; Sitnicka et al, 1996; Solar 
et al, 1998; Yagi et cd,, 1999). Furthermore, TPO has receptor binding region 
containing neurotrophin-like motif and highly homologous to that of EPO (Li and 
Dai., 1995). The protective effects have been well-established in these molecules 
(Sadamoto et al., 1998; Bernaudin et al, 1999; Brines et al, 2000; Siren et al, 2000; 
Galvin and Oorschot, 2003; Kumral et al, 2003 and 2004). TPO may act through the 
EPO receptor (Rouleau et al” 2004) and protect the brain against HI damage. 
With our rat model, we demonstrated that TPO treatment exerted neuroprotective 
effect on the neonatal brain as it improved the relative brain weight, cortex area and 
gross injury score in p7 rats sacrificed 1 week post-surgery, especially in those with 
mild damage (Table 4.7). TPO reversed the reduction in relative weight of the right 
hemisphere in the mild damage model similar to the normal pups. Although TPO 
could not reverse it back to normal, the damage of the severe damage model was also 
reduced. However, the damage of the cortex area of p7 rats was not improved by 
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TPO. 
The effect of TPO lasted beyond the period of administration in medium-term 
since improvements in the absolute and relative brain weight and gross injury score 
were evident in the severe damage model 3 weeks post-surgery. However, the 
functional test we performed did not show any significant damage in the 
vehicle-treated group. The major difficulty of the test is the high variation among 
individual rats. Although trends of difference were observed in the mean value of the 
holding time and percentage turn bias, they were not significant statistically. We may 
modify our protocols to include some training sessions before the test or perform 
more trials for each test. Also, since the effect of TPO was more prominent in the p7 
rats with mild damage, we are going to include this model for the functional tests and 
observe if a more consistent result could be obtained. Furthermore, the present 
functional test involved only sensorimotor function of the rats. Tests identifying other 
brain functions, for example the spatial detection and the learning and memory ability, 
should also be included in further study to have a full elucidation of the effect of TPO. 
Some frequently used tests in HI rat model included Morris water maze and shock 
avoidance test (Young et al, 1986; McClure et al., 2007; McClean and Nunez, 2008). 
For p l 4 rat model, although the absolute weight of the total brain and both 
hemispheres were improved by TPO treatment, the percentage damage was not 
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significantly different from the vehicle-treated group. The cortex area and the gross 
injury score were not significantly improved by TPO treatment. The effect of TPO in 
p i4 rats was less obvious. 
The difference of TPO effect may due to progressing nature of HI damage and 
different vulnerability patterns of the brain in the two postnatal ages. In our study, the 
right cortex areas of p7 and p l 4 rats with severe damage were not improved at 7 days. 
However, other study showed that the damage was actually still progressing at this 
point (Carloni et al., 2008). The damage of the vehicle-treated group might continue 
to worsen while the effect of TPO might be detected in later stage of the damage 
development. The cerebral cortex of p7 was more vulnerable than hippocampus but in 
pi3，the relative vulnerability of hippocampus drastically increased (Towfighi et al., 
1997). The hippocampus area should also be included to have a more comprehensive 
evaluation of the effect of TPO. We anticipated measuring the cortex area of the rats 
sacrificed 3 weeks post-surgery and the hippocampus area of the rats with severe 
damage, but due to the time limit, the measurement cannot be completed and 
presented in this article. 
Our results on the effects of TPO, however, are different from those reported by 
Ehrenreich et al. (2005). Their study suggested that TPO has proapoptotic effect in the 
Levine model using p i 4 Wistar-Imamichi rats and all outcomes were measured only 
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at day 3 post-treatment. They detected an increase in neuronal cell death 3 days after 
the surgery. However, one interesting finding is that the induced apoptosis was only 
observed in early postmitotic neurons, but not in precursors and rarely in mature 
neurons. We speculated that the apoptotic death observed is a possible damage control 
mechanism, which was operated to dispose damaged neurons but spared the 
precursors at the early stage of damage. In present study, we followed the rats for a 
longer period and did notice reduced damage after TPO treatment at 7-21 days post 
HI insult. Although significant improvement was not observed in every measurement 
we recorded, TPO did not increase the damage in the neonatal brains of p7 and p l4 
rats. Since the damage was evolving during the growth of the rats, observation of 
longer period should be done before drawing a concrete conclusion on the effect of 
TPO in p l 4 rats. However, one important factor should be noticed is that this study 
used a different rat strain from the Ehrenreich's study. It is possible that the two 
strains have different responses towards damage and drugs as observed in other rat 
strains (Sauter and Rudin, 1995). Although there is no direct evidence showing that 
Wistar-Imamichi and SD rats have different response towards HI and TPO, they did 
perform differently in many other aspects, for example, response to electrical 
activation of oocytes (Mizutani et al., 2004), microsomal carbonyl reductase activity 
and metabolized rate of antidiabetic drug, acetohexamide (Imamura et al., 1995; 
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Imamura and Shimada, 2005). 
This study investigated the neuroprotective effect of TPO on neonatal rat model 
of HI of different postnatal ages with various degrees of damage. We showed that 
TPO protected brains of p7 rats at 7 and 21 days post-insult but did not significantly 
reversed their damage in p l4 rats at day 7. We anticipated that longer-term 
observation, e.g. 6 months, and a larger battery of functional outcomes should be 
included in further study to confirm the effect of TPO in a more clinically-relevant 
point of view. 
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Number of death Number of survival 
Time of Damage 
sacrifice treatment Sham- TPO- Vehicle- Sham- TPO- Vehicle-
operated treatment treated operated treatment treated 
p7 rat model 
0 2 0 1 6 1 5 1 6 
1 week 
Severe 0 1 1 26 26 27 
3 weeks Severe 0 1 1 12 21 19 
p i4 rat model 
1 week Severe 0 0 1 11 26 | 24 " 
Table 4.1. Mortality of animals in HI damage models. There were no differences in 
the mortality of the three groups in the models. The number of surviving rats 
represented the final sample size of each group. 
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Fig 4.1. Body and brain weights of p7 mild HI damage model 1 week post-surgery. HI 
damage reduced (A) body weight, (B) total brain weight, (C) weights of the right and 
left hemispheres of the vehicle-treated animals, compared with those of the 
sham-operated counterparts. TPO treatment did not significantly change these 
parameter outcomes. (D) The relative damage of the right brain was significantly 
reduced in the TPO-treated animals compared with the vehicle-treated animals. Data 
are expressed as mean + SEM (* p < 0.05, ** p < 0.005, *** p < 0.0005 
vehicle-treated group vs. sham-operated group; # p < 0.05 TPO-treatment group vs. 
vehicle-treated group;八 p < 0.05，八八 p < 0.005 sham-operated group vs. 














































































































































































































Gross Frequency (relative frequency %) 
injury score Sham-operated TPO-treatment Vehicle-treated 
0 16 (100) 8 (53.3) 7 (43.8) 
1 0 (0) 7(46.7) 4 (25.0) 
2 0(0) 0 (0) 1 (6.3) 
3 0(0) 0 (0) 2 (12.5) 
4 ^ 2(12.5) 
Total 
Table 4.2. Frequency table for the gross injury score of p7 mild damaged animals 1 
week post-surgery. The distribution of the score in each group was shown with the 
relative frequency calculated. The vehicle-treated group had significantly higher score 
than the sham-operated group (p < 0.005). The TPO-treatment group showed no 
difference with the other two groups. 
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Fig 4.3. Morphology of the cortex and the hippocampus of p7 mild damage model 
1 -week post surgery. In the sham-operated and TPO-treatment groups, the cortex and 
hippocampus of the two hemispheres were similar in size. In the vehicle-treated group, 
HI insult caused shrinkage of the cortex and the hippocampus of the right hemisphere. 
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Fig 4.4. Cortex and hippocampus areas of p7 mild damage model 1-week post surgery. 
(A) The right cortex and (C) hippocampus areas of the vehicle-treated group were 
smaller than those of the sham-operated and TPO-treatment groups. The 
vehicle-treated group had more damage in (B) cortex and (D) hippocampus than the 
sham-operated and TPO-treatment groups. Data are expressed as mean 土 SEM (* p < 
0.05，** p < 0.005，*** p < 0.0005 vehicle-treated group vs. sham-operated group; # p 
< 0.05 TPO-treatment group vs. vehicle-treated group;八八 p < 0.005 sham-operated 
group vs. TPO-treatment group; NS = not significant). 
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Fig 4.5, Body and brain weights of p7 severe HI damage model 1 week post-surgery. 
The HI damaged vehicle-treated group showed lower weight in (A) the body, (B) the 
total brain, and (C) the left and right hemisphere than the sham-operated group. The 
TPO-treatment and vehicle-treated groups had similar measurements in these weights. 
(D) The percentage damage of the vehicle-treated group was higher than the 
sham-operated groups. The damage of the TPO-treatment group was lower than that 
of the vehicle-treated group but was still higher than that of the sham-operated ones. 
Data are expressed as mean + SEM (* p < 0.05, ** p < 0.005, *** p < 0.0005 
vehicle-treated group vs. sham-operated group; # p < 0.05 TPO-treatment group vs. 
vehicle-treated group;八 p < 0.05，八八 p < 0.005 sham-operated group vs. 
TPO-treatment group; NS = not significant). 
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Gross Frequency (relative frequency %) 
injury score Sham-operated TPO-treatment Vehicle-treated 
0 26(100) 18(69.2) 10(37.0) 
1 0(0) 4(15.4) 6 (22.2) 
2 0(0) 1(3.8) 3(11.1) 
3 0(0) 1(3.8) 3(11.1) 
4 ^ 2 (7.7) 5(18.5) 
Total 26 26 27 
Table 4.3. Frequency table for the gross injury score of p7 severe damaged animals 1 
week post-surgery. The animals received vehicle showed higher score than 
sham-operated ones (p < 0.0005). TPO treatment reduced the score significantly (p < 
0.05). 
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Fig 4.6. Morphology of the cortex of p7 severe damage model 1 -week post surgery. In 
the sham-operated group, the cortex of the two hemispheres was similar in size. HI 
insult caused shrinkage of the right cortex in the vehicle-treated group. TPO treatment 
reduced the shrinkage but the reduction was not significant statistically. 
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Fig 4.7. Cortex areas of p7 severe damage model 1 week post-surgery. (A) The right 
cortex area of the vehicle-treated group was lower than that of the sham-operated 
group. The TPO-treatment group had similar area to the vehicle-treated group (B) 
More damage was observed in the vehicle-treated group than in the sham-operated 
group. The TPO-treatment group had similar percentage damage to the vehicle-treated 
group. Data are expressed as mean + SEM (*** p < 0.0005 vehicle-treated group vs. 
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Fig 4.8. Body and brain weights of p7 severe HI damage model 3 weeks post-surgery. 
(A) There was a trend showing a difference in the body weight among the three 
groups (p = 0.070). The weights of (B) the whole brain and (C) the right hemisphere 
of the three groups were significantly different. These weights of the vehicle-treated 
group were significantly lower than those of the sham-operated group. The 
TPO-treatment group had higher weights than the vehicle-treated group but still lower 
than the sham-operated group. (D) The vehicle-treated group had more damage than 
the sham-operated group. The TPO-treatment reduced the damage significantly but 
still its damage was higher than the sham-operated group. Data are expressed as + 
SEM (* p < 0 . 0 5 ， p < 0.005，*** p < 0.0005 vs. sham-operated group; # p < 0.05, 
## p < 0.005 vs. vehicle-treated group). 
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Gross injury Frequency (relative frequency %) 
score Sham-operated TPO-treatment Vehicle-treated 
0 12(100) 17(81.0) 9 (47.4) 
1 ^ 3 (14.3) 5 (26.3) 
2 1 (4.8) 3(15.8) 
3 ^ ^ 
4 ^ 2(10.5) 
Total � 12 I 21 I 19 
Table 4.4. Frequency table for the gross injury score of p7 animals with severe HI 
treatment 3 weeks post-surgery. The vehicle-treated animals had significantly higher 
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Fig 4.9. Functional assessments of p7 rat model with severe HI treatments 3 weeks 
post surgery. There were no statistical differences observed in between the three 
groups in both (A) holding time in grip traction test and (B) percentage turn in 
elevated body swing test. Data are expressed as mean + SEM. 
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Fig 4.10. Body and brain weights of p l4 severe HI damage model 1 week 
post-surgery. (A) Pups in the vehicle-treated group had lower body weight than the 
sham-operated group. (B) The whole brain and (C) the left brain weights of the 
vehicle-treated group were significantly lower than the sham-operated group. These 
weights of the TPO-treatment group were higher than those of the vehicle-treated 
group and were similar to those of the sham-operated group. (C) The weight of the 
right hemisphere in the vehicle-treated group was lower than in the sham-operated 
group. The TPO-treatment group showed higher right brain weight than the 
vehicle-treated group but still lower than the sham-operated group. (D) The 
sham-operated group had less damage when compared with the vehicle-treated and 
TPO-treatment groups. Data are expressed as mean + SEM (* p < 0.05，*** p < 
0.0005 vehicle-treated group vs. sham-operated group; # p < 0.05 TPO-treatment 
group vs. vehicle-treated group;八八 p < 0.005, ^^^ p < 0.0005 sham-operated group 
vs. TPO-treatment group; NS = not significant). 
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^ . . Frequency (relative frequency %) 
Gross injury — 
score Sham-operated TPO-treatment Vehicle-treated 
0 11 (100) 12 (46.2) 3(11.1) 
1 4(15.4) 5(18.5) 
2 0j[0) 2 (7.7) 6 (22.2) 
3 3(11.5) 1(3.7) 
4 ^ 5(19.2) 9(33.3) 
Total 11 I 26 24 
Table 4.5. Frequency table for the gross injury score of p i4 animals with severe HI 
treatment 3 weeks post-surgery. Both vehicle-treated and TPO-treatment groups had 
higher score than the sham-operated group (p < 0.0005 and p < 0.05 respectively). 
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Fig 4.11. Morphology of the cortex of p l4 severe damage model 1-week post surgery. 
In the sham-operated group, the cortex of the two hemispheres was similar in size. HI 
insult caused shrinkage of the right cortex in the vehicle-treated. TPO treatment 
reduced the damage but the reduction did not reach statistical significance. 
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Fig 4.12. Cortex areas of p l4 severe damage model 1 week post-surgery. (A) The 
right cortex area of the vehicle-treated group was lower than that of the sham-operated 
group. The TPO-treatment group had similar area to the vehicle-treated group (B) 
More damage was observed in the vehicle-treated group than in the sham-operated 
group. The TPO-treatment group had similar percentage damage to the vehicle-treated 
group. Data are expressed as mean + SEM (* p < 0.05, ** p < 0.005 vehicle-treated 
group vs. sham-operated group; ^ p < 0.05 sham-operated group vs. TPO-treatment 
group; NS = not significant). 
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. ^ Treatment group 
Time of HI White cell Red cell Platelet 
(blood sample/ o . 
harvest Damage ^ (IOVL) (10^^/L) (10^/L) 
sample size) 
p7 rat model 
Sham-operated (15/16) 6.3土0.3 | 4.82土0.13 | 1153土28 
Mild TPO-treatment (14/15) 6.8土0.5 4.99±0.15 1291±52 
Vehicle-treated (12/16) 6.2土0.3 4.91 土 0 . 1 6 1214土36 
1 week 
Sham-operated (22/26) 6.2土0.2 4.95土0.11 1243土35 
Severe TPO-treatment ( 2 5 / 2 6 ) ^ ： ^ 5 . 2 9 土 0 . 1 4 1406±60 
Vehicle-treated (26/27) 6.6土0.3 5.25土0.10 1365土54 
Sham-operated (12/12) 8.3土0.4 6.32土0.16 1113土47 
3 weeks Severe TPO-treatment (21/21) 7.6土0.3 6.11土0.14 1127土35 
Vehicle-treated (19/19) 7 .4土0 .36 .09土0 .15 1151 土47 
p i 4 rat model 
I S h a m - � p e r a t e d ( l l / l l ) I | 5 . 7 5 ± 0 . 2 0 | 1215土58 
1 week Severe TPO-treatment (26/26) 7.6土0.3 5.85土0.10 1185±35 
Vehicle-treated (24/24) 7.3土0.3 6.12土0.14 1179土34 
Table 4.6. Blood cell counts in experimental animals. Blood sample numbers were 
less than the sample sizes of other measurements due to blood clotting. No 

































































































































































































































































































































































































































































































































































Effects of thrombopoietin on the proliferation of primary mouse 
neural stem/ progenitor cells in culture 
5.1 Summary of experimental settings 
Experiments were performed to investigate the change in NSP proliferation 
under the effect of: 
(1) EGF or bFGF to determine the mitogen (20 ng/ml EGF, 20 ng/ml bFGF or a 
combination of the two) used for later assays; 
(2) TPO treatments in different concentrations (0.1 to 200 ng/ml); and 
(3) selected concentrations of TPO (0.2 to 20 ng/ml) in combination with hypoxia. 
The proliferation of NSP in culture was detected using the neurosphere assay. 
Neurosphere-derived single cells (P3-7) were seeded in 96-well plate and incubated 
for 8 - 1 2 days. The amount of neurospheres were counted and classified into their 
sizes: small, medium and large (Fig 3.5) (Ciccolini and Svendsen, 1998). The 
neurospheres were dissociated into single cells and the total number of cells and 
viability were recorded. The expression of neural progenitor cell marker, Musashi-1, 
was detected in the NSPs. 
5.2 Results 
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5.2.1 Effect of EGF or bFGF withdrawal on NSP proliferation 
The total number of neurospheres was 115.8 per 2000 cells seeded at the 
beginning of culture with both EGF and bFGF (n = 4). In the culture with bFGF alone 
(n = 3)，the total number of neurospheres dropped to 53.7 (Fig 5.1). A trend showed 
that the drop was observed (p = 0.109). The reduction was essentially in the 
population of large and medium neurospheres (p = 0.109 in both comparisons). 
The mean total viable cells were counted after neurosphere dissociation. In 
bFGF-only culture, the total viable cells were only about 11% of that in the culture 
with EGF and bFGF (Fig 5.2A). A trend of drop was observed (p = 0.109). 
The culture with 20 ng/ml EGF (n = 4) showed a trend to have more small and 
medium spheres but less large spheres than the culture with both mitogens (p = 0.068 
in both comparisons). The presence of 20 ng/ml EGF only led to increase in the 
number of spheres when compared with the culture with both mitogens (p = 0.068) 
(Fig 5.1). 
However, the number of total dispensed viable cells in the culture with 20 ng/ml 
EGF was only about half of the cell proliferated in the culture with both mitogens (Fig 
5.2A) but this drop was not yet statistically significant (p = 0.144). 
The viability of the cultures under the three conditions was similar (Fig 5.2B). 
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5.2.2 Dose effect of TPO treatment on NSP proliferation 
In the neurosphere assay, bFGF was withdrawn and the culture contained only 20 
ng/ml EGF in order to detect the effect of TPO on the NSP culture under stress. The 
total number of neurospheres and the subpopulations in cultures with TPO at various 
concentrations were similar (Fig 5.3). 
The number of total dispensed viable cells in the cultures with 0.2, 1 and 2 ng/ml 
TPO (n = 11,7, 11) was significantly higher than the culture without TPO (p = 0.013, 
0.043 and 0.026 respectively) while a trend of increase was observed in cultures with 
0.1 and 10 ng/ml TPO (n = 7 for both concentrations and p = 0.063 and 0.091 
respectively). Although an increase in the mean number of total viable cells under 20 
and 200 ng/ml TPO was observed, the increase was not yet reached significance (n = 
4 for both concentrations, p = 0.273) (Fig 5.4A). At the same time, the viability of the 
culture with different TPO treatments was similar to the culture without TPO (Fig 
5.4 A). 
5.2.3 Effect of hypoxia 
The culture with 20 ng/ml EGF-only under hypoxia showed significantly less 
neuropsheres in small size (p = 0.016) but more neurospheres in medium size (p = 
0.008) than the normoxic culture (n = 10). There was a trend that the number of large 
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neurospheres was also increased under hypoxic condition (p = 0.082). In total, the 
culture under hypoxia gave rinse to more neurospheres than the culture under 
normoxia (p = 0.013) (Fig 5.5). 
The total viable cells obtained after the dissociation of neurospheres in the 
culture under hypoxia was higher in amount than that in the culture under normoxic (p 
= 0 . 0 2 8 ) (Fig 5.6A). The viability of the cells was similar in the hypoxia and 
normoxia (Fig 5.6B). 
5.2.4 Effect of TPO treatment in combination with hypoxia 
By using the multilevel models, changes brought by TPO treatments were similar 
in either hypoxic and normoxic conditions (n = 10 for all TPO concentrations). It 
showed that the TPO treatment and the change in oxygen content did not interfere 
with each other. This applied to all of the parameters we recorded, including number 
of neuropsheres in different sizes, total number of nuerosphere, viability and the 
number of total dispensed viable cells. 
The addition of TPO (0.2, 2，10，20 ng/ml) reduced the number of small 
neurospheres compared with the culture without TPO under hypoxia (p = 0.046，0.034, 
0.011 and 0.011 respectively) (Fig 5.7A). TPO treatment at 2，10 and 20 ng/ml 
increased the number of medium neurospheres (p = 0.024, 0.005 and 0.009 
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respectively) (Fig 5.7B). Although the increase in the number of medium 
neurospheres at 0.2 ng/ml TPO did not reach significance (p = 0.066), the number of 
larger neurospheres at this concentration was significantly higher than the culture 
without TPO (p = 0.050) (Fig 5.7C). There was a trend of increasing number of large 
neurospheres at 2 ng/ml TPO (p = 0.057). The total numbers of neurospheres in 
culture with 0.2 and 20 ng/ml TPO was similar to the control without TPO. In the 
cultures with 2 and 10 ng/ml TPO, the increase in total number of neurospheres was 
statistically significant (p = 0.050 and 0.005) (Fig 5.7D). 
The total dispensed cell number increased under the addition of TPO (0.2, 2，10, 
20 ng/ml), in comparison to the culture without TPO under hypoxia (p = 0.017，0.037, 
0.012 and 0.009 respectively) (Fig 5.8A). The viability of the cells was not altered by 
the addition of TPO (Fig 5.8B). 
5.2.5 Detection of neural progenitor cell marker 
Obtained from cultures with 20 ng/ml EGF, the neurospheres expressed the 
neural progenitor cell marker, Musashi-1. With the addition of 20 ng/ml TPO, the 
expression of Musahi-1 was also observed. It showed that they were consisted of 
neural stem/ progenitor cells (Fig 5.9). 
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5.3 Discussion 
To establish the NSP culture in vitro, the standard method is to obtain primary 
cells from the fetal or adult brain tissues (Gage, 2000). The tissues can be originated 
from the striatum, cortex, mesencephalon and spinal cord from developing mouse 
brains (Reynolds et al., 1992) or subventricular zone and hippocampus in adult (Gage, 
2000). The dissociated cells are cultured in the presence of mitogens. The cells then 
proliferated to form neurospheres (Reynolds and Weiss, 1992; Reynolds et al., 1992). 
On removal of mitogens and addition of serum, the neurosphere as a whole and the 
single cells dissociated from the neurospheres can be differentiated into neurons, 
astrocytes and oligodendrocytes (Rietze and Reynolds, 2006). Recently, the protocols 
of adherent culture of NSP have been developed (Conti et al., 2005; Pollard et al., 
2006). Fetal and adult NSPs were expanded as adherent monolayer in the presence of 
EGF and bFGF. These cells could form neurospheres if detached and could 
differentiate into neurons. However, until now, neurosphere culture remains a 
frequently adopted procedure for expanding NSPs. In this study, we successfully 
established the primary culture of NSPs with free floating neurospheres derived from 
the E15 mouse hippocampus tissues. These neurospheres showed immunoreactivity of 
Musashi-1, which is a neural stem/ progenitor cell marker (Sakakibara et al., 1996; 
Pevny and Rao, 2003). 
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EGF and bFGF are two important mitogens stimulating the proliferation of NSPs 
but their relative importance remains controversial. Different studies have shown EGF 
(Reynolds and Weiss, 1992; Reynolds et al” 1992) or bFGF (Gritti et al, 1996; Qian 
et al., 1997) alone can induce proliferation of multipotent precursor cells from either 
embryo or adult. Some other groups showed the requirement of both mitogens for 
induction of NSP proliferation (Weiss et cd., 1996). One group has suggested that the 
two mitogens act on the same cell population and bFGF promotes the acquisition of 
EGF responsiveness in NSPs to proliferate (Ciccolini and Svendsen, 1998). Another 
group argued that there are actually two different cell populations responsive to EGF 
and bFGF separately (Tropepe et al, 1999). These contradictions may be caused by 
the use of cells from different tissue origins, developmental stage and species/strains 
of animals (Smith et al., 2003). With this uncertainty, we carried out a pilot study to 
determine the use of mitogens suitable for our experimental settings. The culture with 
both EGF and bFGF sustained the highest rate of NSP proliferation. Withdrawing one 
of the two mitogens hindered NSP proliferation. The condition of bFGF-only was too 
stressful for NSP to maintain proliferation and thus was excluded for further 
experiment. We chose to use the culture contained only 20 ng/ml EGF to detect the 
effect of TPO on the NSP culture under stress. 
Although TPO sustained proliferation of hematopoietic stem cells (Ku et al., 
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1996; Sitnicka et al., 1996; Solar et al, 1998; Yagi et al., 1999)，its effect on neural 
stem cells was not yet investigated. In our study, the addition of TPO increased the 
total viable cells number without affecting the viability. Immunoreactivity against 
Musashi-1 antibody of the neurospheres was still present after TPO treatment. This 
evidence suggested that TPO can stimulate the proliferation of NSP. Horie et al. (2008) 
showed that mild hypoxia increased the proliferation of NSPs and neuronal 
differentiation in vitro. Burgers et al (2008) further decreased oxygen level to zero in 
culture and showed that anoxia stimulated proliferation of adult NSPs. Zhao et al. 
(2008) suggested that this increase in proliferation induced by hypoxia was mediated 
via hypoxia-inducible factor l a (HIF-la) signaling pathway. The result of our 
experiment using fetal NSPs was in line with these studies. The exposure to hypoxia 
increased the total number of neurospheres, with major increase in the medium-size 
subpopulation, and the total viable cell in NSP culture. The combination of hypoxia 
and TPO treatment in our experiment did not interfere with each other on NSP 
proliferation. 
In contrast, Ehrenreich et al. (2005) showed that either TPO or hypoxia alone 
increased cell death in in vitro neuronal culture. However, they also showed the 
TPO-induced cell death were restricted in early post-mitotic neurons but never in 
precursor cells. Unlike our study, their study did not include the investigation of the 
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effect of TPO on primary culture of NSPs, which may respond to TPO and hypoxia 
differently from the differentiated cells. In our study, TPO increased the proliferation 
of NSPs in both normoxia and hypoxia. This may increase the regenerative capacity 
of the HI damaged brain and recover the neuronal death. 
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Fig 5.1. The number of neurospheres under different concentrations of mitogens. Culture 
with bFGF-only gave rinse to neurospheres only in small and medium size. EGF-only 
culture led to more neurospheres and a larger portion of small and medium neuropsheres 
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Fig 5.2. The number of total viable cells and the viability under different combinations of 
mitogens. (A) Culture with bFGF-only and EGF-only had low number of viable cells 
than culture with both EGF and bFGF. (B) The viability of the cultures under different 
conditions was similar. Data are expressed as mean 土 SEM. 
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Fig 5.3. The number of neurospheres under different concentrations of TPO. The numbers 
of neurospheres in (A) small, (B) medium and (C) large size were not change under 
different TPO concentrations. (D) The total numbers of neurospheres in cultures with 
TPO at various concentrations were similar. Data are expressed as mean 土 SEM. 
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Fig 5.4. The number of total viable cells and the viability under different concentrations 
of TPO. (A) The number of viable cells increased significantly under 0.2，1 and 2 ng/ml 
TPO. (B) The viability of the cultures with TPO was similar to the culture without TPO. 
Data are expressed as mean 土 SEM (* p < 0.05 vs. no TPO control). 
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Fig 5.5. The number of neurospheres under hypoxic and normoxic conditions. Hypoxia 
reduced the amount of small neurospheres, but increased the amount of medium ones. 
The total number was also increased. Data are expressed as mean 土 SEM (# p < 0.05). 
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Fig 5.6. The number of total viable cells and the viability under hypoxic and normoxic 
conditions. (A) The total viable cell number increased under hypoxia. (B) The viability of 
the cells under hypoxia and normoxia was similar. Data are expressed as mean 土 SEM (# 
p = 0.028). 
97 
A Small B Medium 
40-1 o Normoxic 100-1 o Normoxic 
73 • Hypoxic -o • Hypoxic 
I I 30. I f - ； ； ； 
I f 2�. l | . T ^ ^ i I I 
feo * * * fe o 70- J _ 
| | 1 � _ * | | s o -
0*^  1 1 I 1 1 SO-* 1 1 1 1 1 
0 0.2 2 10 20 0 0.2 2 10 20 
TPO concentration (ng/ml) TPO concentration (ng/ml) 
C Large D Total 
25n o Normoxic 140-i o Normoxic 
•g • Hypoxic • Hypoxic 
OJ -S 20- -J. 2 "O * 
1 1 t i 120- T l x T 
p . f - i I n 
0-1 1 1 1 1 1—— 80-1 1 1 1 1 1 
0 0.2 2 10 20 0 0.2 2 10 20 
TPO concentration (ng/ml) TPO concentration (ng/ml) 
Fig 5.7. The number of neurospheres produced under normoxia and hypoxia with 
different concentrations of TPO. (A) The number of small neurospheres was reduced by 
TPO at all concentrations compared with the control without TPO. (B) The number of 
medium neurospheres increased at 2, 10 and 20 ng/ml TPO, but (C) the number of large 
neurospheres was not different from the control without TPO at all concentrations of TPO. 
(D) An increase in total number of neurosphere was observed in the culture with 10 ng/ml 
TPO. Data are expressed as mean 土 SEM (* p < 0.05 vs. culture without TPO under 
hypoxia). 
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Fig 5.8. The number of total viable cells and the viability under normoxia and hypoxia 
with different concentrations of TPO. (A) The cell number increased with the addition of 
TPO at all concentrations. (B) The viability of the cells under different TPO 
concentrations was similar in the hypoxia. Data are expressed as mean 土 SEM (* p < 0.05 
vs. culture without TPO under hypoxia). 
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Fig 5.9. Expression of neural progenitor cell marker in neurospheres. Neurosphere was 
formed in the culture with 20 ng/ml EGF-only (A, B, C) without TPO and (D，E，F) with 
20 ng/ml TPO. It was stained with (B, E) propidium iodide (red in color) in the nucleus 




HIE contributes 23% of neonatal death globally while survivors have a high 
chance to develop neurological problems (Lawn et al, 2005). The neurological 
outcomes were determined by the severity and timing of the insult (Alvarez-Diaz et 
al.’ 2007). HIE is an evolving process and the damage on brain is developed through a 
complicated mechanism involving numerous biochemical pathways. Although many 
therapeutic agents, for example EPO, melatonin, BDNF etc., have been proven useful 
in animal models, there is still no standardized intervention to prevent neural damage. 
Therapeutic hypothermia has been shown to be neuroprotective in randomized 
controlled trials (Schulzke et al” 2007; Jacobs et al; 2008). However, adverse effects, 
such as bradycardia and seizures, were observed (Eicher et al., 2005b), and the 
efficacy is greatly reduced or lost if the cooling is delayed (Gunn and Bennet, 1999, 
Karlsson et al., 2008). 
In our study, the potential of TPO as a novel neuroprotective agent was 
demonstrated in two models. In the in vivo HI model of neonatal rat, TPO reduced the 
damages brought by HI insult in gross injury score, relative brain weight, cortex and 
hippocampus areas in rats with mild or severe damage. The effect of TPO could be 
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observed in both 1 week and 3 weeks post-surgery. In the in vitro model of primary 
mouse NSP culture with the exposure to hypoxia, TPO increased the total viable cell 
number in addition to the increase in cell number brought by hypoxia. Since NSPs can 
renew themselves and differentiate into neurons, astrocytes and oligodendrocytes, 
they are potential candidates for the regeneration of brain tissues after damage (Miller, 
2006; Okana et al, 2007). The increase in NSPs by TPO may help to repair the 
damaged brain. To distinguish NSPs and different neural cell types in a mixed 
population, immunofluorescence staining can be used. In our study, NSPs were 
stained with Musashi-1 while another commonly used marker is nestin (Lendahl et al., 
1990; Dahlstrand et al., 1992). Some well-recognized markers include class III 
P-tubulin (Lee et al, 1990 a and b) and MAP 2 (Ballough et al, 1995) for detecting 
neurons, GFAP (Eng et al., 1971; Bignami et al., 1972) for detecting astrocytes and 
0 4 (Schachner et al, 1981; Sommer and Schachner, 1981) for oligodendrocytes. 
For further study, more efforts can be placed on the functional outcome 
assessments to have a better picture of the effect of TPO. A larger battery of tests for 
both sensorimotor functions and spatial learning and memory ability of the animals 
should be performed. The follow-up duration should also be lengthened to determine 
the long-term effect of TPO. The effect of TPO on NSP differentiation is also an 
important question to address. The differentiation ability of NSPs proliferated under 
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the TPO stimulation should be determined to ensure functional neural cells can be 
generated. 
To fully understand the functions of TPO against HI damage, further study on the 
signaling pathways elicited by TPO should be carried out. Pathways such as PBK/Akt 
and Ras/Raf /MAPK signaling pathways may be involved. The Akt signaling is 
activated in response to proliferation signals in mouse neural stem/progenitor cells 
(Molina-Holgado et al., 2007) and rat adult hippocampal progenitors (Peltier et al., 
2007). MAPK cascades are involved in proliferation mediated by vascular endothelial 
growth factor and basic fibroblast growth factor (Xiao et al, 2007) and by 
hypoxia/reoxygenation (Sung et al, 2007) while inhibition of MAPK cascades 
hinders the proliferation of NSPs (Ceccatelli et al, 2004 and Kalluri et al., 2007). 
Since TPO induced the phosphorylation of Akt, Erk and MAPK in hematopoietic cell 
line (Yoshida et al., 2008)，it may also elicit the same signals in neural system to 
protect the brain. 
Another possible signaling pathway involved is HIF-la pathway. Again, TPO 
induced HIF- l a expression in hematopoietic stem cells (Kirito et al., 2005; Yoshida 
et al, 2008). HIF- la is the subunit of HIF with oxygen-dependent degradation 
domain, which marks the protein for degradation under normoxic condition and is 
stabilized by hypoxia (Huang and Bunn, 2003; Ziello et al, 2007). HIF- la regulates 
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et al., 2008). HIF-la is the subunit of HIF with oxygen-dependent degradation 
domain, which marks the protein for degradation under normoxic condition and is 
stabilized by hypoxia (Huang and Bunn, 2003; Ziello et al” 2007). HIF-la regulates 
many genes for hypoxia adaptation, for example, EPO, vascular endothelial growth 
factor, glucose transporter, glycolytic enzymes, heme oxygenase and tyrosine 
hydroxylase (Jelkmann, 2005). Years ago, the transcription factor HIF-la was found 
to be induced in rat brain after focal ischemia (Bergeron et al” 1999). Recently, some 
studies using Levine's HI rat model revealed that NSP population and neurogenesis 
were increased in the rat brain after the insult (Felling et al., 2006; Yang and Levison, 
2006). In vitro culture of NSPs revealed that hypoxia increased HIF-la and knocking 
out HIF-la abolished the increase in NSP proliferation after hypoxia (Zhao et al., 
2008). TPO may further stabilize more HIF-la and thus enhance the proliferation of 
NSPs. 
TPO has been tested under various clinical trials, for example, using TPO to 
increase the platelet counts of patients after chemotherapy (Vadhan-Raj et al., 2003; 
Angiolillo et al., 2005) or hematopoietic stem cell transplantation (Nash et al, 2000). 
TPO mobilized the stem/ progenitor cells to peripheral blood and accelerated 
hematopoietic recovery after chemotherapy (Somlo et al, 1999; Gajewski et al., 
2002). From these studies, the patients, including children, showed well-tolerance 
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towards recombinant human TPO and even so it is highly possible that it is also safe 
for neonatal patients with HIE. 
Since HIE is a complicated disease involving numerous reactions and is 
progressing with time, one therapeutic agent may not be able to target all mechanisms 
engaged. We may further anticipate the study of the use of TPO in combination with 
other therapeutic interventions, for example hypothermia, to protect the brain against 
HI damage. 
As we have shown that TPO can increase the population of NSPs, leading to the 
increase of the regenerative power of the brain, it may also be beneficial for 
treatments of other acute neural damages, e.g. stroke and brain trauma; and 
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